https://curecurrent.com/trials/use-of-amphetamine-type-stimulants-its-relationship-with-hiv-incidence-and-antiretroviral-adherence-among-msm-and-tg-128009https://curecurrent.com/trials/alere-combo-and-alere-q-detect-in-an-hiv-prep-program-in-thailand-128010https://curecurrent.com/trials/bone-health-and-vitamin-d-status-128011https://curecurrent.com/trials/using-nevirapine-to-prevent-mother-to-child-hiv-transmission-during-breastfeeding-128012https://curecurrent.com/trials/netherlands-cohort-study-on-acute-hiv-infection-128013https://curecurrent.com/trials/a-proof-of-concept-trial-to-evaluate-the-safety-and-efficacy-of-ub-421-plus-chidamide-in-changing-hiv-reservoirs-128014https://curecurrent.com/trials/immunologic-predisposition-of-hiv-patients-to-develop-methicillin-resistant-staphylococcus-aureus-mrsa-colonization-and-128015https://curecurrent.com/trials/evaluating-the-pharmacokinetics-safety-and-tolerability-of-doravirine-mk-1439-and-doravirine-lamivudine-tenofovir-disopr-128016https://curecurrent.com/trials/a-safety-study-of-brentuximab-vedotin-in-participants-with-hiv-128017https://curecurrent.com/trials/extraordinarily-fun-training-project-in-compulsory-secondary-education-sexually-transmitted-infections-128018https://curecurrent.com/trials/hiv-substance-users-released-from-jail-128019https://curecurrent.com/trials/exploratory-study-on-the-role-of-the-digestive-microbiota-in-adults-living-with-hiv-1-128020https://curecurrent.com/trials/biological-therapy-in-treating-patients-at-high-risk-or-with-lymphoma-lymphoproliferative-disease-or-malignancies-128021https://curecurrent.com/trials/universal-hiv-screening-and-targeted-hcv-screening-in-emergency-department-128022https://curecurrent.com/trials/improving-effective-contraceptive-use-among-opioid-maintained-women-stage-ii-128023https://curecurrent.com/trials/expanding-prep-by-embedding-unannounced-snaps-navigators-in-high-sti-testing-clinical-sites-128024https://curecurrent.com/trials/probiotic-supplementation-for-those-immune-non-responders-with-hiv-1-infection-128025https://curecurrent.com/trials/a-crossover-study-evaluating-3-non-medicated-silicone-ivrs-128026https://curecurrent.com/trials/swaziland-hiv-incidence-measurement-survey-2-128027https://curecurrent.com/trials/implementation-of-a-collaborative-care-model-to-manage-depression-among-adolescents-and-young-adults-in-hiv-services-in-128028https://curecurrent.com/trials/interface-hiv-patients-tracer-for-clinical-assistance-and-research-during-covid-19-128029https://curecurrent.com/trials/effects-of-biktarvy-on-cfr-in-stable-hiv-patients-128030https://curecurrent.com/trials/markers-of-neurological-damage-post-covid-19-in-plwh-128031https://curecurrent.com/trials/situational-analysis-of-hiv-related-disability-in-the-context-of-ivory-coast-128032https://curecurrent.com/trials/acceptability-feasibility-and-effectiveness-of-online-peer-support-group-for-art-adherence-among-youth-128033https://curecurrent.com/trials/an-observational-retrospective-database-analysis-to-evaluate-raltegravir-based-regimens-including-nuc-sparing-regimens-i-128034https://curecurrent.com/trials/promoting-engagement-in-the-drug-resistant-tb-hiv-care-continuum-in-south-africa-praxis-study-128035https://curecurrent.com/trials/effects-of-vsl-3-on-neuro-cognitive-profile-of-hiv-patients-128036https://curecurrent.com/trials/randomized-trial-of-an-hiv-prevention-and-relationship-education-program-for-young-male-couples-128037https://curecurrent.com/trials/efprezimod-alfa-cd24fc-mk-7110-administration-to-decrease-low-density-lipoprotein-ldl-and-inflammation-in-human-immunode-128038https://curecurrent.com/trials/evaluating-the-safety-and-pharmacokinetics-of-vrc01-vrc01ls-and-vrc07-523ls-potent-anti-hiv-neutralizing-monoclonal-anti-128039https://curecurrent.com/trials/bone-mineral-density-substudy-an-ancillary-study-to-mtn-003-128040https://curecurrent.com/trials/reaching-adolescent-girls-and-young-women-through-girl-friendly-drug-vendors-128041https://curecurrent.com/trials/safety-tolerability-ddi-short-course-treatment-of-ltbi-infection-with-high-dose-rifapentine-and-isoniazid-or-standard-is-128042https://curecurrent.com/trials/positive-attitudes-concerning-infant-feeding-a-questionnaire-for-women-living-with-hiv-128043https://curecurrent.com/trials/careconekta-a-smartphone-app-to-improve-engagement-in-hiv-care-128044https://curecurrent.com/trials/evaluating-a-community-based-exercise-intervention-with-adults-living-with-hiv-an-interrupted-time-series-study-128045https://curecurrent.com/trials/effectiveness-of-intensive-adherence-counselling-among-people-living-with-hiv-aids-with-low-level-viraemia-in-uganda-128046https://curecurrent.com/trials/radiomics-model-for-the-diagnosis-of-pneumocystis-jirovecii-pneumonia-in-non-hiv-patients-128047https://curecurrent.com/trials/community-based-interventions-to-improve-hiv-outcomes-in-youth-a-cluster-randomised-trial-in-zimbabwe-128048https://curecurrent.com/trials/experimental-pneumococcal-carriage-in-people-living-with-hiv-128049https://curecurrent.com/trials/effectiveness-of-booster-with-1-or-2-doses-of-hav-vaccine-among-hiv-infected-patients-128050https://curecurrent.com/trials/computer-aided-screening-for-tuberculosis-in-low-resource-environments-128051https://curecurrent.com/trials/satisfaction-of-hiv-infected-patients-treated-with-cabotegravir-rilpivirine-injectable-dual-therapy-128052https://curecurrent.com/trials/thermocoagulation-for-treatment-of-precancerous-cervical-lesions-128053https://curecurrent.com/trials/charisma-expansion-study-128054https://curecurrent.com/trials/multicenter-performance-study-of-quadquik-invitro-diagnostic-device-128055https://curecurrent.com/trials/rectal-microbicide-acceptability-tolerability-and-adherence-128056https://curecurrent.com/trials/evaluation-of-a-story-within-a-story-the-novel-chharge-intervention-component-128057https://curecurrent.com/trials/small-volume-blood-testing-validity-and-acceptability-for-hiv-1-and-hepatitis-b-tinies-for-bbvs-128058https://curecurrent.com/trials/a-randomized-controlled-trial-of-an-antiretroviral-treatment-adherence-intervention-for-hiv-african-americans-128059https://curecurrent.com/trials/activity-pacing-in-plwh-with-fatigue-symptoms-128060https://curecurrent.com/trials/health-and-justice-a-continuum-of-care-for-hiv-and-su-for-justice-involved-young-adults-phase-2-128061https://curecurrent.com/trials/efficacy-of-lauric-acid-a-dietary-fatty-acid-in-modifying-the-latent-reservoir-of-hiv-128062https://curecurrent.com/trials/evaluating-distribution-of-a-tenofovir-douche-with-tap-water-douching-and-simulated-receptive-anal-intercourse-128063https://curecurrent.com/trials/point-of-care-tests-to-identify-opportunistic-infections-in-advanced-hiv-patients-in-mexico-city-128064https://curecurrent.com/trials/multicenter-performance-study-of-triquik-invitro-diagnostic-device-128065https://curecurrent.com/trials/medico-social-description-of-seniors-living-with-hiv-associated-with-a-qualitative-survey-on-their-care-in-the-paris-reg-128066https://curecurrent.com/trials/an-integrated-strategy-to-support-antiretroviral-therapy-and-pre-exposure-prophylaxis-adherence-for-hiv-prevention-in-pr-128067https://curecurrent.com/trials/open-study-pain-management-treatment-needs-interviews-128068https://curecurrent.com/trials/the-effect-of-yoga-for-stress-among-hiv-patients-in-indonesia-128069https://curecurrent.com/trials/cabozantinib-s-malate-in-treating-patients-with-advanced-solid-tumors-and-human-immunodeficiency-virus-128070https://curecurrent.com/trials/study-to-evaluate-pharmacokinetic-and-safety-of-albuvirtide-between-intravenous-drip-and-intravenous-injection-128071https://curecurrent.com/trials/hiv-and-other-risk-factors-for-esophageal-squamous-cell-carcinoma-in-malawi-128072https://curecurrent.com/trials/optimizing-malaria-treatment-for-hiv-malaria-co-infected-individuals-128073https://curecurrent.com/trials/seroincidence-study-among-men-who-have-sex-with-men-and-transgender-women-the-imprep-seroincidence-study-128074https://curecurrent.com/trials/testing-the-safety-and-efficacy-of-commercial-drug-biktarvy-in-subjects-known-to-have-the-184-resistance-mutation-to-a-c-128075https://curecurrent.com/trials/autologous-transplant-in-hiv-patients-bmt-ctn-0803-128076https://curecurrent.com/trials/tracking-and-exploring-the-source-of-viral-rebound-128077https://curecurrent.com/trials/dolutegravir-in-reservoirs-128078https://curecurrent.com/trials/effect-on-the-hiv-diagnosis-rates-of-integration-of-aids-indicator-conditions-into-the-hospital-information-systems-128079https://curecurrent.com/trials/supportive-coaching-intervention-in-plwha-128080https://curecurrent.com/trials/digital-health-feedback-system-dhfs-for-longitudinal-monitoring-of-arvs-used-in-hiv-pre-exposure-prophylaxis-prep-128081https://curecurrent.com/trials/retention-in-hiv-care-for-hispanic-immigrants-128082https://curecurrent.com/trials/digital-health-feedback-system-for-longitudinal-measurement-of-medication-adherence-during-anti-retroviral-arv-therapy-128083https://curecurrent.com/trials/feasibility-and-acceptability-of-digital-pills-to-monitor-prep-adherence-in-msm-with-substance-use-128084https://curecurrent.com/trials/integrated-stepped-care-for-unhealthy-alcohol-use-in-hiv-128085https://curecurrent.com/trials/the-effect-of-combination-mindfulness-spiritual-based-cognitive-therapy-plus-hypnosis-in-hiv-patients-with-depression-128086https://curecurrent.com/trials/study-to-evaluate-the-effects-of-cenicriviroc-mesylate-on-arterial-inflammation-in-people-living-with-hiv-128087https://curecurrent.com/trials/phase-3-safety-and-effectiveness-trial-of-dapivirine-vaginal-ring-for-prevention-of-hiv-1-in-women-128088https://curecurrent.com/trials/point-of-care-ultrasound-for-patients-with-hiv-128089https://curecurrent.com/trials/sexual-risks-in-prep-users-128090https://curecurrent.com/trials/coaching-for-hcv-and-hiv-128091https://curecurrent.com/trials/secondary-distribution-of-hiv-self-tests-an-innovative-strategy-for-promoting-partner-testing-and-reducing-hiv-risk-128092https://curecurrent.com/trials/identification-of-the-pre-exposure-prophylaxis-prep-cascade-for-women-128093https://curecurrent.com/trials/point-of-care-tests-for-syphilis-and-hiv-128094https://curecurrent.com/trials/optimizing-mhealth-for-adherence-monitoring-and-intervention-128095https://curecurrent.com/trials/allogeneic-transplant-in-hiv-patients-bmt-ctn-0903-128096https://curecurrent.com/trials/stepped-care-for-youth-living-with-hiv-128097https://curecurrent.com/trials/engaging-seronegative-youth-to-optimize-hiv-prevention-continuum-128098https://curecurrent.com/trials/long-term-follow-up-of-study-participant-treated-with-lentiviral-based-genetically-modified-autologous-cell-product-agt1-128099https://curecurrent.com/trials/an-antiretroviral-treatment-interruption-ati-study-to-evaluate-the-impact-of-genetically-modified-autologous-cells-agt10-128100https://curecurrent.com/trials/effect-of-a-mobile-health-intervention-on-treatment-adherence-128101https://curecurrent.com/trials/hiv-and-stis-clinical-study-in-germany-128102https://curecurrent.com/trials/prospective-observational-cohort-hiv-sti-study-in-europe-128103https://curecurrent.com/trials/integrating-safer-conception-counseling-to-transform-hiv-family-planning-services-128104https://curecurrent.com/trials/study-of-hiv-hcv-aps-and-phylogenetics-for-pwid-128105https://curecurrent.com/trials/navigating-insurance-coverage-expansion-nice-128106https://curecurrent.com/trials/northwest-therapies-trauma-psilocybin-study-compassionate-use-study-128107https://curecurrent.com/trials/autologous-cd4-t-cells-in-hiv-c34-cxcr4-128108https://curecurrent.com/trials/evaluation-of-six-month-hiv-treatment-dispensing-in-south-africa-128109https://curecurrent.com/trials/botswana-combination-prevention-project-128110https://curecurrent.com/trials/pilot-rct-of-pos4health-for-nonadherent-hiv-substance-users-128111https://curecurrent.com/trials/r5-integrase-study-in-hiv-1-naive-patients-128112https://curecurrent.com/trials/hiv-drug-switch-followed-by-hcv-therapy-in-hiv-hcv-co-infection-128113https://curecurrent.com/trials/st-petersburg-pain-and-alcohol-intervention-with-naltrexone-and-gabapentin-128114https://curecurrent.com/trials/efficacy-and-safety-of-tca-vs-eca-for-the-treatment-of-ain-in-hiv-positive-patients-128115https://curecurrent.com/trials/impact-of-male-provider-phone-calls-to-increase-men-s-clinic-linkage-after-hivst-128116https://curecurrent.com/trials/immediate-or-deferred-pre-exposure-prophylaxis-for-hiv-prevention-safe-options-for-pregnant-and-lactating-women-128117https://curecurrent.com/trials/the-benefits-of-immediate-treatment-initiation-without-immunovirological-data-compared-to-conventional-bic-ftc-taf-treat-128118https://curecurrent.com/trials/hybrid-sttr-intervention-for-heterosexuals-anonymous-testing-and-confidential-care-linkage-128119https://curecurrent.com/trials/safety-and-pharmacokinetics-of-dapivirine-vaginal-ring-in-post-menopausal-women-128120https://curecurrent.com/trials/comparing-brief-alcohol-interventions-for-hiv-hcv-co-infected-persons-128121https://curecurrent.com/trials/randomized-double-blind-placebo-controlled-trial-followed-by-single-arm-treatment-of-pro-140-128122https://curecurrent.com/trials/using-most-to-optimize-an-hiv-care-continuum-intervention-for-vulnerable-populations-128123https://curecurrent.com/trials/peer-driven-intervention-to-seek-test-treat-heterosexuals-at-high-risk-for-hiv-128124https://curecurrent.com/trials/timely-initiation-of-hiv-antiretroviral-therapy-among-those-who-delay-decline-128125https://curecurrent.com/trials/mobile-strategies-for-women-s-and-children-s-health-optimizing-adherence-and-efficacy-of-pmtct-art-128126https://curecurrent.com/trials/peer-driven-intervention-to-enroll-minorities-women-in-hiv-aids-clinical-trials-the-act2-project-128127https://curecurrent.com/trials/supporting-health-behavior-among-persons-living-with-hiv-using-tech-most-and-behavioral-economics-128128https://curecurrent.com/trials/pomalidomide-for-kaposi-sarcoma-in-people-with-or-without-hiv-128129https://curecurrent.com/trials/tmc114ifd3001-study-providing-continued-access-to-treatment-with-darunavir-drv-ritonavir-rtv-in-hiv1-infected-adults-ado-128130https://curecurrent.com/trials/a-spanish-language-intervention-to-enhance-routine-hiv-patient-care-delivery-care-spanish-128131https://curecurrent.com/trials/tui-na-for-peripheral-neuropathy-among-people-with-hiv-128132https://curecurrent.com/trials/computerized-counseling-to-promote-positive-prevention-and-hiv-health-in-kenya-128133https://curecurrent.com/trials/rituximab-plus-chop-chemotherapy-for-diffuse-large-b-cell-lymphoma-128134https://curecurrent.com/trials/rapid-hiv-treatment-initiation-access-and-engagement-in-care-128135https://curecurrent.com/trials/hiv-oral-testing-infographic-experiment-128136https://curecurrent.com/trials/evaluating-demand-generation-stylish-man-stylish-living-for-hiv-prevention-family-planning-services-rakai-uganda-128137https://curecurrent.com/trials/hiv-non-occupational-post-exposure-prophylaxis-pep-128138https://curecurrent.com/trials/convalescent-plasma-for-covid-19-research-donor-study-128139https://curecurrent.com/trials/trial-to-assess-the-continued-safety-of-and-adherence-to-a-vaginal-ring-containing-dapivirine-in-women-128140https://curecurrent.com/trials/a-safety-study-of-two-dapivirine-tmc120-vaginal-gels-in-the-united-states-128141https://curecurrent.com/trials/to-assess-continued-safety-of-and-adherence-to-the-dapivirine-25-mg-vaginal-ring-004-in-healthy-hiv-negative-women-128142https://curecurrent.com/trials/study-of-dapivirine-vaginal-ring-vr-in-adolescents-128143https://curecurrent.com/trials/2-5-intermittent-caloric-restriction-in-hiv-128144https://curecurrent.com/trials/intervention-program-to-address-ptsd-in-people-living-with-hiv-128145https://curecurrent.com/trials/primary-infection-cohort-128146https://curecurrent.com/trials/safety-and-efficacy-trial-of-a-dapivirine-vaginal-matrix-ring-in-healthy-hiv-negative-women-128147https://curecurrent.com/trials/assisted-partner-services-and-hivst-in-western-kenya-128148https://curecurrent.com/trials/single-dose-postpartum-vitamin-a-supplementation-of-mothers-and-neonates-128149https://curecurrent.com/trials/prospective-observational-epidemiologic-study-of-maraviroc-s-safety-128150https://curecurrent.com/trials/differences-in-immune-response-among-hiv-1-infected-individuals-with-previous-or-current-covid-19-covihdis-128151https://curecurrent.com/trials/a-unified-intervention-for-young-gay-and-bisexual-men-s-minority-stress-mental-health-and-hiv-risk-128152https://curecurrent.com/trials/impact-of-hypovitaminosis-d-on-bone-disease-in-hiv-infected-patients-128153https://curecurrent.com/trials/ai-youmian-love-better-sleep-for-people-living-with-hiv-128154https://curecurrent.com/trials/high-intensity-lipid-lowering-following-acute-coronary-syndromes-for-persons-living-with-hiv-128155https://curecurrent.com/trials/study-to-evaluate-the-safety-and-how-the-body-handles-a-single-dose-of-subcutaneous-sc-and-intravenous-iv-budigalimab-in-128156https://curecurrent.com/trials/a-study-of-islatravir-mk-8591-in-trans-and-gender-diverse-participants-mk-8591-035-128157https://curecurrent.com/trials/microbicide-prep-acceptability-among-mothers-and-male-partners-in-africa-128158https://curecurrent.com/trials/couple-user-preferences-in-dual-purpose-prevention-products-128159https://curecurrent.com/trials/assessment-of-aspire-and-hope-adherence-128160https://curecurrent.com/trials/treating-chronic-pain-and-depression-in-hiv-patients-in-primary-care-settings-128161https://curecurrent.com/trials/standardized-patient-encounters-to-improve-prep-counseling-for-adolescent-girls-and-young-women-in-kenya-128162https://curecurrent.com/trials/establishing-novel-antiretroviral-imaging-for-hair-to-elucidate-non-adherence-enlighten-128163https://curecurrent.com/trials/intravenous-chemotherapy-or-oral-chemotherapy-in-treating-patients-with-previously-untreated-stage-iii-iv-hiv-associated-128164https://curecurrent.com/trials/universal-coverage-of-antiretroviral-treatment-in-senegal-128165https://curecurrent.com/trials/integrating-mental-health-into-a-hiv-clinic-to-improve-outcomes-among-tanzanian-youth-128166https://curecurrent.com/trials/ing200336-pharmacokinetic-and-safety-study-in-pregnant-women-with-human-immuno-virus-infection-128167https://curecurrent.com/trials/technology-enhanced-peer-navigation-to-improve-idus-engagement-in-hiv-care-128168https://curecurrent.com/trials/a-structural-hiv-prevention-intervention-targeting-high-risk-women-128169https://curecurrent.com/trials/mo-betta-trial-in-transwomen-for-optimization-of-art-128170https://curecurrent.com/trials/th9507-extension-study-in-patients-with-hiv-associated-lipodystrophy-128171https://curecurrent.com/trials/storytelling-intervention-to-promote-cervical-cancer-screening-uptakes-among-malawian-women-living-with-human-immunodefi-128172https://curecurrent.com/trials/iprep-study-2-evaluating-enhanced-prep-packages-for-young-female-sex-workers-in-kisumu-kenya-128173https://curecurrent.com/trials/hiv-test-and-treat-to-prevent-hiv-transmission-among-msm-and-transgender-women-128174https://curecurrent.com/trials/a-pilot-study-comparing-the-immunogenicity-of-fendrix-vs-double-dose-engerix-b-in-hiv-infected-non-responders-to-standar-128175https://curecurrent.com/trials/a-study-to-evaluate-efficacy-and-safety-of-darunavir-cobicistat-emtricitabine-tenofovir-alafenamide-d-c-f-taf-fixed-dose-128176https://curecurrent.com/trials/hiv-reservoir-reduction-with-interleukin-2-128177https://curecurrent.com/trials/comparing-mobile-health-strategies-to-improve-pre-exposure-prophylaxis-use-prep-for-hiv-prevention-128178https://curecurrent.com/trials/antiretroviral-regime-for-viral-eradication-in-newborns-128179https://curecurrent.com/trials/study-of-effects-of-tenofovir-on-bone-health-and-kidneys-during-pregnancy-and-breastfeeding-128180https://curecurrent.com/trials/zambia-common-elements-treatment-approach-pilot-study-128181https://curecurrent.com/trials/effectiveness-of-a-telephone-delivered-behavioral-treatment-to-improve-the-quality-of-life-of-older-adults-with-hiv-128182https://curecurrent.com/trials/pain-inflammation-and-cannabis-in-hiv-128183https://curecurrent.com/trials/improving-antiretroviral-therapy-adherence-through-urban-gardening-and-nutritional-counseling-in-the-dominican-republic-128184https://curecurrent.com/trials/a-study-evaluating-an-integrated-pharmacy-digital-diary-and-delivery-strategy-to-increase-prep-use-among-msm-and-tgw-128185https://curecurrent.com/trials/a-network-intervention-for-prevention-of-hiv-infection-in-chennai-india-1-128186https://curecurrent.com/trials/functional-cure-study-of-anti-pd-l1-antibody-asc22-in-combination-with-chidamide-in-hiv-infected-patients-with-antiviral-128187https://curecurrent.com/trials/pc4prep-integrating-prep-into-primary-care-128188https://curecurrent.com/trials/immunomodulation-using-vb-201-to-reduce-arterial-inflammation-in-treated-hiv-vital-hiv-trial-128189https://curecurrent.com/trials/the-effect-of-arsenic-trioxide-on-eliminating-hiv-1-reservoir-combined-with-cart-128190https://curecurrent.com/trials/a-registry-study-of-covid-19-serologic-and-virologic-testing-to-accelerate-recovery-and-transition-128191https://curecurrent.com/trials/observational-study-on-patients-with-hiv-aids-ospwh-128192https://curecurrent.com/trials/the-effect-of-chimeric-antigen-receptor-car-t-cell-therapy-on-the-reconstitution-of-hiv-specific-immune-function-128193https://curecurrent.com/trials/simplified-treatment-of-anti-retrovirus-in-china-c-star-128194https://curecurrent.com/trials/dolutegravir-plus-lamivudine-simplified-therapy-128195https://curecurrent.com/trials/feasibility-and-acceptability-of-a-substance-use-screening-and-brief-intervention-for-youth-living-with-hiv-in-kenya-128196https://curecurrent.com/trials/the-influence-of-having-bariatric-surgery-on-the-pharmacokinetics-safety-and-efficacy-of-the-novel-non-nucleoside-revers-128197https://curecurrent.com/trials/predicting-visceral-leishmaniasis-in-hiv-infected-patients-128198https://curecurrent.com/trials/a-trial-of-same-day-testing-and-treatment-to-improve-outcomes-among-symptomatic-patients-newly-diagnosed-with-hiv-128199https://curecurrent.com/trials/high-dose-chemotherapy-with-transplantation-of-gene-modified-haematopoietic-stem-cells-for-hiv-positive-patients-with-ma-128200https://curecurrent.com/trials/analysis-of-the-nasal-mucosal-immune-response-in-hiv-infection-128201https://curecurrent.com/trials/inflammation-nk-cells-antisense-protein-and-exosomes-and-correlation-with-immune-response-during-hiv-infection-128202https://curecurrent.com/trials/hpv-self-sampling-to-improve-access-to-cervical-cancer-screening-for-persons-with-hiv-and-or-underserved-individuals-128203https://curecurrent.com/trials/mgd014-in-hiv-infected-individuals-on-suppressive-antiretroviral-therapy-128204https://curecurrent.com/trials/advanced-hiv-outcomes-for-rapid-art-128205https://curecurrent.com/trials/beta-testing-of-a-smartphone-app-for-hiv-prevention-in-malaysian-msm-128206https://curecurrent.com/trials/safety-and-immunogenicity-of-candidate-hiv-vaccines-given-sequentially-128207https://curecurrent.com/trials/the-effect-of-aspirin-on-hiv-disease-progression-among-hiv-infected-individuals-initiating-anti-retroviral-therapy-128208https://curecurrent.com/trials/preventing-hiv-sti-in-urban-adolescents-via-an-mhealth-primary-care-intervention-128209https://curecurrent.com/trials/vicriviroc-in-hiv-treatment-experienced-subjects-study-p04889am8-completed-128210https://curecurrent.com/trials/the-women-s-hiv-seroincidence-study-isis-128211https://curecurrent.com/trials/hiv-incidence-and-participation-retention-in-pune-india-128212https://curecurrent.com/trials/feasibility-and-acceptability-study-of-an-individual-level-behavioral-intervention-for-individuals-with-acute-and-early-128213https://curecurrent.com/trials/preparing-for-international-prevention-trials-involving-hiv-infected-individuals-in-care-settings-128214https://curecurrent.com/trials/feasibility-study-of-a-multi-component-intervention-for-black-men-who-have-sex-with-men-128215https://curecurrent.com/trials/population-effects-of-antiretroviral-therapy-to-reduce-hiv-transmission-popart-128216https://curecurrent.com/trials/evaluation-of-web-based-interventions-to-support-people-living-with-hiv-in-the-adoption-of-health-behaviors-128217https://curecurrent.com/trials/perturbing-of-hiv-reservoir-with-immune-stimulation-128218https://curecurrent.com/trials/treatment-of-recently-acquired-hepatitis-c-with-the-3d-regimen-or-g-p-128219https://curecurrent.com/trials/optimizing-the-efficiency-and-implementation-of-cash-transfers-to-improve-adherence-to-antiretroviral-therapy-128220https://curecurrent.com/trials/motivational-enhancement-system-for-adherence-mesa-for-youth-starting-art-128221https://curecurrent.com/trials/cd4-zeta-gene-modified-t-cells-with-and-without-exogenous-interleukin-2-il-2-in-hiv-patients-128222https://curecurrent.com/trials/s0816-fludeoxyglucose-f-18-pet-ct-imaging-and-combination-chemotherapy-with-or-without-additional-chemotherapy-and-g-csf-128223https://curecurrent.com/trials/leveraging-the-emergency-department-to-engage-african-american-women-in-hiv-pre-exposure-prophylaxis-128224https://curecurrent.com/trials/bidirectional-upbeat-communication-and-differentiated-distanced-care-for-young-people-128225https://curecurrent.com/trials/catalysing-the-containment-of-covid-19-128226https://curecurrent.com/trials/keep-it-up-2-0-a-comparison-of-two-online-hiv-intervention-programs-for-young-men-who-have-sex-with-men-128227https://curecurrent.com/trials/a-pragmatic-trial-of-an-adaptive-ehealth-hiv-prevention-program-for-diverse-adolescent-msm-128228https://curecurrent.com/trials/immune-reconstitution-as-a-determinant-of-adverse-effects-to-new-antiretroviral-therapy-in-persons-with-advanced-hiv-inf-128229https://curecurrent.com/trials/study-to-assess-safety-and-ability-to-induce-immune-responses-of-hiv-1-vaccines-m3-and-m4-given-alone-or-in-combination-128230https://curecurrent.com/trials/safety-of-and-immune-response-to-a-prime-boost-vaccine-regimen-in-hiv-uninfected-vaccine-naive-adults-128231https://curecurrent.com/trials/efficacy-and-tolerability-of-dtg-plus-3tc-in-hiv-infected-adults-with-virologically-suppression-and-tdf-toxicity-128232https://curecurrent.com/trials/safety-of-and-immune-response-to-a-dna-hiv-vaccine-pga2-js7-boosted-with-a-modified-vaccinia-hiv-vaccine-mva-hiv62-in-he-128233https://curecurrent.com/trials/evaluating-the-immunogenicity-of-the-aidsvax-b-e-vaccine-and-the-mva-hiv62b-vaccine-in-healthy-hiv-1-uninfected-adults-w-128234https://curecurrent.com/trials/short-term-intensified-chemo-immunotherapy-in-hiv-positive-patients-with-burkitt-lymphoma-128235https://curecurrent.com/trials/integration-of-hpv-vaccination-and-hpv-based-cervical-screening-into-arv-clinics-the-h2victory-trial-128236https://curecurrent.com/trials/immune-therapy-and-analytical-treatment-interruption-in-hiv-participants-who-received-an-allogeneic-stem-cell-transplant-128237https://curecurrent.com/trials/evaluation-of-safety-tolerability-and-immune-responses-of-ebola-s-and-marburg-vaccines-in-healthy-adults-128238https://curecurrent.com/trials/the-hiv-testing-trends-and-outcomes-at-a-johannesburg-trauma-icu-unit-128239https://curecurrent.com/trials/the-chaps-trial-combined-hiv-adolescent-prep-and-prevention-128240https://curecurrent.com/trials/positive-health-check-evaluation-trial-128241https://curecurrent.com/trials/the-effectiveness-of-cbi-on-depression-and-adherence-in-hiv-infected-adolescents-128242https://curecurrent.com/trials/hiv-cov-in-ukraine-nl-128243https://curecurrent.com/trials/prep-talk-prep-uptake-with-young-black-msm-and-their-close-friends-128244https://curecurrent.com/trials/daily-trimethoprim-sulfamethoxazole-or-weekly-chloroquine-among-adults-on-art-in-malawi-128245https://curecurrent.com/trials/comparison-of-men-s-prevention-apps-to-research-efficacy-128246https://curecurrent.com/trials/cisplatin-and-radiation-therapy-in-treating-patients-with-hiv-associated-locally-advanced-cervical-cancer-128247https://curecurrent.com/trials/covid-19-quantitative-antibody-titers-booster-vaccinations-128248https://curecurrent.com/trials/adherence-intervention-for-hiv-infected-drug-users-128249https://curecurrent.com/trials/mobile-application-to-improve-care-coordination-among-hiv-clinic-and-substance-use-treatment-providers-128250https://curecurrent.com/trials/partner-notification-of-sexually-transmitted-infections-stis-in-testing-centers-128251https://curecurrent.com/trials/safety-tolerability-and-efficacy-on-low-density-lipoprotein-cholesterol-ldl-c-of-evolocumab-in-participants-with-human-i-128252https://curecurrent.com/trials/acceptability-of-hiv-oral-prep-among-msm-and-tgw-128253https://curecurrent.com/trials/hiv-acquisition-and-life-course-of-born-abroad-men-who-have-sex-with-men-living-in-ile-de-france-the-ganymede-study-128254https://curecurrent.com/trials/clinical-study-of-abcd-in-the-treatment-of-cryptococcal-meningitis-128255https://curecurrent.com/trials/behavioural-text-messages-to-improve-retention-in-care-in-south-africa-128256https://curecurrent.com/trials/promoting-engagement-in-the-drug-resistant-tb-hiv-care-continuum-in-south-africa-128257https://curecurrent.com/trials/kidney-stone-risk-factors-in-patients-infected-with-hiv-128258https://curecurrent.com/trials/incentives-to-promote-sustained-linkage-to-hiv-care-128259https://curecurrent.com/trials/acceptability-feasibility-and-impact-of-oral-hiv-self-testing-for-partner-testing-among-kenyan-adolescent-girls-aged-15-128260https://curecurrent.com/trials/immunological-characteristics-of-a-population-at-risk-of-cholera-after-oral-cholera-vaccine-chovaxim-128261https://curecurrent.com/trials/growth-hormone-dynamics-and-cardiac-steatosis-in-hiv-128262https://curecurrent.com/trials/kingasa-pilot-study-128263https://curecurrent.com/trials/romidepsin-plus-3bnc117-phase-2a-study-128264https://curecurrent.com/trials/an-enhanced-package-of-care-to-reduce-reduce-mortality-in-advanced-hiv-disease-128265https://curecurrent.com/trials/prep-implementation-for-mothers-in-antenatal-care-128266https://curecurrent.com/trials/evaluating-the-safety-tolerability-pharmacokinetics-and-antiviral-activity-of-combinations-of-monoclonal-antibodies-pgt1-128267https://curecurrent.com/trials/developing-a-patient-navigation-intervention-for-prep-continuum-of-care-among-young-latino-msm-preparate-128268https://curecurrent.com/trials/optimizing-hiv-counseling-and-testing-and-referral-through-an-adaptive-drug-use-intervention-128269https://curecurrent.com/trials/mhealth-physical-activity-trial-for-older-hiv-infected-adults-mfit-128270https://curecurrent.com/trials/cannabinoids-in-plwhiv-on-effective-art-128271https://curecurrent.com/trials/positive-connections-copa2-128272https://curecurrent.com/trials/impact-of-a-personalized-multicomponent-exercise-program-in-real-conditions-among-older-adults-with-hiv-128273https://curecurrent.com/trials/increasing-availability-and-acceptability-of-circumcision-in-zambia-128274https://curecurrent.com/trials/computerized-brief-alcohol-intervention-bi-for-binge-drinking-hiv-at-risk-and-infected-women-128275https://curecurrent.com/trials/a-study-to-test-three-experimental-hiv-vaccines-in-healthy-adults-128276https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-reversibility-of-abacavir-lamivudine-dolutegravir-cns-related-neurotoxicity-after-switc-128277https://curecurrent.com/trials/testing-the-addition-of-paclitaxel-and-carboplatin-given-after-standard-chemotherapy-and-radiation-for-cervical-cancer-i-128278https://curecurrent.com/trials/efficacy-and-safety-of-ainuovirine-treating-with-aids-patients-128279https://curecurrent.com/trials/a-research-study-to-see-if-a-change-in-therapy-for-hiv-infection-can-improve-the-immune-response-to-treatment-128280https://curecurrent.com/trials/the-improv-project-improving-mental-health-and-substance-use-treatment-provision-improv-among-people-living-with-hiv-hum-128281https://curecurrent.com/trials/the-hpv-save-study-team-hpv-screening-and-vaccine-evaluation-in-men-who-have-sex-with-men-128282https://curecurrent.com/trials/hpv-save-merck-sub-study-for-preventing-recurrence-of-hsil-128283https://curecurrent.com/trials/evaluation-of-an-adaptative-multidisciplinary-reach-out-program-facilitating-pre-exposition-hiv-prophylaxis-prep-prescri-128284https://curecurrent.com/trials/switch-to-taf-ftc-bic-in-hiv-1-infected-patients-over-65-years-old-at-risk-of-polymedication-128285https://curecurrent.com/trials/effectiveness-of-a-mobile-based-hiv-prevention-intervention-involving-incentive-policy-for-doctors-in-liangshan-china-128286https://curecurrent.com/trials/sexual-and-reproductive-health-including-prep-and-hbv-for-female-sex-workers-in-c-te-d-ivoire-128287https://curecurrent.com/trials/adore-efficacy-of-doravirine-in-adults-living-with-hiv-experiencing-virological-failure-on-first-line-efavirenz-based-an-128288https://curecurrent.com/trials/prevention-of-hiv-in-le-de-france-128289https://curecurrent.com/trials/hiv-self-testing-and-comic-intervention-with-refugee-adolescents-and-youth-128290https://curecurrent.com/trials/promoting-hiv-self-testing-among-msm-during-covid-19-pandemic-128291https://curecurrent.com/trials/a-psychosocial-tele-health-stigma-intervention-for-youth-living-with-hiv-in-vietnam-128292https://curecurrent.com/trials/bridge-improving-hiv-service-delivery-for-people-who-inject-drugs-128293https://curecurrent.com/trials/increasing-msm-in-the-continuum-of-care-in-kazakhstan-128294https://curecurrent.com/trials/strategies-to-improve-kaposi-sarcoma-ks-outcomes-in-zimbabwe-128295https://curecurrent.com/trials/alendronate-for-prevention-of-antiretroviral-therapy-associated-bone-loss-128296https://curecurrent.com/trials/patients-experiences-and-perceptions-of-3tc-dtg-dual-therapy-the-pedal-study-128297https://curecurrent.com/trials/project-pride-promoting-resilience-in-discriminatory-environments-128298https://curecurrent.com/trials/addressing-intimate-partner-violence-mental-health-and-hiv-in-antenatal-care-128299https://curecurrent.com/trials/re-evaluation-of-annual-cytology-using-hpv-testing-to-upgrade-prevention-in-women-living-with-hiv-128300https://curecurrent.com/trials/covid-19-in-patients-with-hiv-128301https://curecurrent.com/trials/linking-persons-with-hiv-discharged-from-jail-with-community-care-128302https://curecurrent.com/trials/poc-strategies-to-improve-tb-care-in-advanced-hiv-disease-128303https://curecurrent.com/trials/monitoring-of-viral-load-in-decentralised-area-in-vietnam-128304https://curecurrent.com/trials/dental-care-of-patients-living-with-hiv-128305https://curecurrent.com/trials/accelerated-prep-access-for-black-msm-and-tw-128306https://curecurrent.com/trials/mr-imaging-and-mr-spectroscopy-of-hiv-128307https://curecurrent.com/trials/the-hiv-functional-cure-potential-of-ub-421-in-art-stabilized-hiv-1-patients-128308https://curecurrent.com/trials/impart-provider-assisted-hiv-partner-notification-128309https://curecurrent.com/trials/strategies-to-optimize-antiretroviral-therapy-services-for-maternal-child-health-the-mch-art-study-128310https://curecurrent.com/trials/use-therapeutic-chinese-massage-to-treat-peripheral-neuropathy-in-people-with-hiv-128311https://curecurrent.com/trials/effectiveness-implementation-of-a-behavioral-intervention-for-adherence-and-substance-use-in-hiv-care-in-south-africa-128312https://curecurrent.com/trials/peer-support-to-mitigate-the-impact-of-stigma-in-young-hiv-pregnant-postpartum-women-128313https://curecurrent.com/trials/postpartum-adherence-clubs-for-antiretroviral-therapy-128314https://curecurrent.com/trials/systems-analysis-and-improvement-approach-for-prevention-of-mtc-hiv-transmission-128315https://curecurrent.com/trials/frailty-in-people-living-with-hiv-aged-70-years-or-more-128316https://curecurrent.com/trials/peer-intervention-latino-immigrant-msm-128317https://curecurrent.com/trials/buprenorphine-to-improve-hiv-care-engagement-and-outcomes-128318https://curecurrent.com/trials/open-label-extension-ole-of-the-tdf2-study-botswana-128319https://curecurrent.com/trials/study-for-evaluation-of-the-safety-pharmacokinetics-and-antiviral-activity-of-ub-421-subcutaneous-formulation-in-hiv-inf-128320https://curecurrent.com/trials/the-hiv-functional-cure-potential-of-ub-421-in-art-stabilized-hiv-1-patients-128321https://curecurrent.com/trials/the-bright-program-building-resilience-in-hiv-together-128322https://curecurrent.com/trials/feasibility-of-identifying-enrolling-and-following-acute-and-early-hiv-1-infected-individuals-128323https://curecurrent.com/trials/project-retain-providing-integrated-care-for-hiv-infected-crack-cocaine-users-128324https://curecurrent.com/trials/a-phase-i-trial-to-evaluate-the-safety-and-immunogenicity-of-eod-gt8-60mer-vaccine-adjuvanted-128325https://curecurrent.com/trials/the-intensified-treatment-monitoring-strategy-to-prevent-accumulation-of-drug-resistance-itrema-trial-128326https://curecurrent.com/trials/integrating-prep-into-family-planning-services-at-title-x-clinics-in-the-southeastern-us-128327https://curecurrent.com/trials/a-phase-1-2a-study-of-pgt121-vrc07-523ls-and-pgdm1400-monoclonal-antibodies-in-hiv-uninfected-and-hiv-infected-adults-128328https://curecurrent.com/trials/notification-of-donors-with-positive-microbiology-markers-128329https://curecurrent.com/trials/relative-mitochondrial-toxicity-of-tenofovir-alafenamide-taf-vs-tenofovir-disoproxil-fumarate-tdf-128330https://curecurrent.com/trials/medication-assisted-treatment-for-injecting-drug-users-in-vietnam-128331https://curecurrent.com/trials/impact-of-the-epidemic-of-covid-19-infection-among-people-living-with-hiv-sars-cov-2-128332https://curecurrent.com/trials/impact-of-containment-and-the-current-epidemic-on-the-sexual-risk-taking-of-people-using-prep-to-prevent-hiv-infection-128333https://curecurrent.com/trials/effects-of-mindfulness-training-on-chronic-inflammation-in-hiv-infected-adults-128334https://curecurrent.com/trials/fastlane-ii-reducing-sex-drug-and-mental-health-risk-128335https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-immunogenicity-of-v114-followed-by-pneumovax-23-in-adults-infected-with-128336https://curecurrent.com/trials/acceptability-of-simultaneous-screening-for-viral-hepatitis-b-c-and-hiv-among-drug-users-in-non-conventional-structures-128337https://curecurrent.com/trials/age-17-follow-up-of-home-visiting-intervention-128338https://curecurrent.com/trials/driving-reduced-aids-associated-meningo-encephalitis-mortality-128339https://curecurrent.com/trials/adolescent-transition-to-adult-care-for-hiv-infected-adolescents-in-kenya-128340https://curecurrent.com/trials/hiv-prevention-and-prep-intervention-for-sgm-adolescents-and-parents-hey-friend-128341https://curecurrent.com/trials/cell-phone-technology-targeting-art-and-naltrexone-adherence-and-alcohol-use-128342https://curecurrent.com/trials/immune-responses-and-immunological-tolerance-after-rabies-booster-vaccination-in-hiv-infected-adults-128343https://curecurrent.com/trials/cell-phone-technology-targeting-art-adherence-and-drug-use-128344https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-hiv-clade-c-dna-vaccine-and-mf59-or-as01b-adjuvanted-clade-c-env-protein-vac-128345https://curecurrent.com/trials/immune-responses-after-a-four-site-intradermal-rabies-booster-vaccination-in-hiv-infected-adults-128346https://curecurrent.com/trials/comparing-treatments-for-hiv-infected-opioid-users-in-an-integrated-care-effectiveness-study-choices-scale-up-128347https://curecurrent.com/trials/utilizing-computed-tomographic-angiography-to-evaluate-coronary-artery-disease-in-patients-on-long-term-antiretroviral-t-128348https://curecurrent.com/trials/community-and-systems-level-hiv-prevention-in-peru-128349https://curecurrent.com/trials/hiv-1-gag-conserved-element-dna-vaccine-p24ce-vaccine-study-128350https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-env-a-b-c-a-e-gag-c-dna-and-gp120-a-b-c-a-e-protein-gla-se-hiv-vaccines-give-128351https://curecurrent.com/trials/integrase-and-maraviroc-intensification-in-neurocognitive-dysfunction-inmind-128352https://curecurrent.com/trials/clinical-effectiveness-and-safety-of-amphotericin-b-with-flucytosine-fluconazole-therapy-for-cryptococcal-meningitis-128353https://curecurrent.com/trials/hiv-non-occupational-post-exposure-prophylaxis-128354https://curecurrent.com/trials/an-observational-study-of-long-term-outcomes-of-hiv-1-infection-in-persons-who-become-hiv-1-infected-after-enrollment-in-128355https://curecurrent.com/trials/treatment-state-and-quality-of-life-in-hiv-infected-patients-in-upper-egypt-128356https://curecurrent.com/trials/impact-of-once-weekly-rifapentine-and-isoniazid-on-the-steady-state-pharmacokinetics-of-dolutegravir-and-darunavir-boost-128357https://curecurrent.com/trials/psychosocial-stress-and-aging-in-hiv-128358https://curecurrent.com/trials/vienna-hiv-infection-via-sex-study-128359https://curecurrent.com/trials/dolutegravir-lamivudine-as-dual-therapy-in-na-ve-hiv-infected-patients-with-documented-m184v-mutation-a-pilot-study-128360https://curecurrent.com/trials/hiv-a6-genome-in-art-unsuccessful-patients-on-dor-128361https://curecurrent.com/trials/safety-and-efficacy-of-triptolide-wilfordii-in-new-onset-hiv-1-infection-128362https://curecurrent.com/trials/biktarvy-for-non-occupational-post-exposure-prophylaxis-npep-128363https://curecurrent.com/trials/preventing-childhood-tuberculosis-in-lesotho-prevent-study-128364https://curecurrent.com/trials/the-lived-experience-of-participants-in-an-african-randomised-trial-128365https://curecurrent.com/trials/use-of-99mtc-tilmanocept-for-imaging-arterial-inflammation-128366https://curecurrent.com/trials/seek-test-and-retain-linkages-for-black-hiv-substance-using-msm-128367https://curecurrent.com/trials/large-scale-transition-to-a-dolutegravir-based-first-line-art-in-the-south-virological-response-and-impact-on-hiv-drug-r-128368https://curecurrent.com/trials/pre-exposure-prophylaxis-dosing-in-pregnancy-to-optimize-hiv-prevention-prep-p-128369https://curecurrent.com/trials/impact-of-hiv-infection-on-clinical-characteristics-and-outcomes-on-stroke-in-uganda-128370https://curecurrent.com/trials/dtap-ipv-hb-prp-t-combined-vaccine-as-a-primary-series-and-a-second-year-of-life-booster-in-hiv-exposed-infected-and-uni-128371https://curecurrent.com/trials/xpert-ultra-and-xpert-hiv-vl-in-people-living-with-hiv-128372https://curecurrent.com/trials/arch-ii-study-alcohol-research-center-on-hiv-study-ii-128373https://curecurrent.com/trials/evaluation-of-hepatitis-c-viral-load-quantification-on-dbs-in-vietnam-128374https://curecurrent.com/trials/leaving-nobody-out-128375https://curecurrent.com/trials/evaluation-of-the-role-of-oct-in-the-detection-of-hiv-associated-neurocognitive-disorder-128376https://curecurrent.com/trials/cbt-and-quality-of-life-of-people-with-hiv-covid-19-and-anxiety-or-depression-128377https://curecurrent.com/trials/preventing-childhood-hiv-rescue-intervention-anrs-12388-prevenir-pev-128378https://curecurrent.com/trials/the-bet-study-intervention-to-reduce-disparities-in-hiv-prevention-and-care-128379https://curecurrent.com/trials/hiv-infection-and-evolvement-of-atherosclerotic-plaque-128380https://curecurrent.com/trials/poor-quality-of-life-associated-with-traditional-chinese-medicine-constitution-in-hiv-infected-men-who-have-sex-with-men-128381https://curecurrent.com/trials/modulating-the-impact-of-critical-events-in-early-hiv-infection-effect-of-art-initiation-and-alcohol-use-128382https://curecurrent.com/trials/enhanced-access-to-hiv-care-for-drug-users-in-san-juan-puerto-rico-128383https://curecurrent.com/trials/mhealth-systems-navigation-breaking-systems-barriers-for-trans-women-living-with-hiv-128384https://curecurrent.com/trials/effect-on-hiv-medications-on-epc-cells-128385https://curecurrent.com/trials/switch-either-near-suppression-or-thousand-128386https://curecurrent.com/trials/estimated-cumulative-incidence-of-zika-infection-at-the-end-of-the-first-epidemic-in-the-french-west-indies-in-a-sample-128387https://curecurrent.com/trials/rct-of-an-integrative-intervention-for-non-treatment-seeking-meth-users-128388https://curecurrent.com/trials/changing-health-through-food-support-chefs-program-128389https://curecurrent.com/trials/cohive-coronavirus-covid-19-outcomes-in-hiv-evaluation-in-resource-limited-settings-128390https://curecurrent.com/trials/prevalence-of-substance-abuse-among-anti-retroviral-treatment-naive-patients-positive-for-hiv-antibodies-128391https://curecurrent.com/trials/hepatocellular-carcinoma-in-hiv-infected-patients-128392https://curecurrent.com/trials/a-cognitive-behavioral-and-structural-hiv-prevention-intervention-for-young-ugandan-sex-workers-128393https://curecurrent.com/trials/a-study-of-gsk1349572-versus-raltegravir-ral-with-investigator-selected-background-regimen-in-antiretroviral-experienced-128394https://curecurrent.com/trials/caregiver-assisted-oral-fluid-based-hiv-screening-in-children-uganda-128395https://curecurrent.com/trials/prep-among-msm-and-tg-in-myanmar-128396https://curecurrent.com/trials/immunogenicity-of-hepatitis-b-vaccination-in-hiv-infected-adults-128397https://curecurrent.com/trials/juvenile-justice-girls-randomized-control-trial-young-adult-follow-up-128398https://curecurrent.com/trials/improving-hiv-tuberculosis-outcomes-in-irkutsk-128399https://curecurrent.com/trials/sport-and-self-esteem-in-patients-living-with-hiv-128400https://curecurrent.com/trials/antiviral-pharmacology-and-adherence-in-drug-users-128401https://curecurrent.com/trials/impact-of-art-adherence-on-hiv-persistence-and-inflammation-128402https://curecurrent.com/trials/safety-tolerability-and-immunogenicity-study-of-3-prime-boost-regimens-for-ebola-vaccines-ad26-zebov-mva-bn-filo-in-heal-128403https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-bictegravir-emtricitabine-tenofovir-alafenamide-versus-dolutegravir-emtrici-128404https://curecurrent.com/trials/the-deliver-health-study-128405https://curecurrent.com/trials/development-of-a-urine-based-point-of-care-test-for-adherence-to-antiretroviral-drugs-128406https://curecurrent.com/trials/safety-and-immunotherapeutic-activity-of-an-anti-pd-1-antibody-cemiplimab-in-participants-with-hiv-1-on-suppressive-cart-128407https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-bictegravir-emtricitabine-tenofovir-alafenamide-versus-abacavir-dolutegravi-128408https://curecurrent.com/trials/a-peer-navigator-model-to-improve-quit-attempts-and-smoking-cessation-rates-among-hiv-positive-smokers-128409https://curecurrent.com/trials/overcoming-geography-with-technology-medical-drones-project-128410https://curecurrent.com/trials/the-development-of-a-mobile-based-app-to-increase-uptake-of-pre-exposure-prophylaxis-prep-by-men-who-have-sex-with-men-i-128411https://curecurrent.com/trials/caregiver-assisted-oral-fluid-based-hiv-screening-in-children-zambia-128412https://curecurrent.com/trials/point-of-care-virologic-testing-to-improve-outcomes-of-hiv-infected-children-128413https://curecurrent.com/trials/prospective-cohort-evaluating-pregnancy-rates-pk-interactions-among-hiv-women-on-efv-initiating-lng-implant-or-dmpa-128414https://curecurrent.com/trials/deliver-direct-acting-antiviral-effects-on-the-liver-128415https://curecurrent.com/trials/innovative-behavioral-economics-incentives-strategies-for-health-128416https://curecurrent.com/trials/evaluating-the-safety-and-efficacy-of-the-vrc01-antibody-in-reducing-acquisition-of-hiv-1-infection-in-women-128417https://curecurrent.com/trials/evaluating-the-safety-and-efficacy-of-the-vrc01-antibody-in-reducing-acquisition-of-hiv-1-infection-among-men-and-transg-128418https://curecurrent.com/trials/antiretroviral-therapy-art-persistence-in-different-body-compartments-in-hiv-negative-msm-128419https://curecurrent.com/trials/management-of-hepatitis-c-in-hiv-infected-injection-drug-users-idus-128420https://curecurrent.com/trials/gender-specific-combination-hiv-prevention-for-youth-in-high-burden-settings-mp3-youth-128421https://curecurrent.com/trials/the-pathogenesis-of-osa-in-people-living-with-hiv-128422https://curecurrent.com/trials/a-study-looking-at-the-effectiveness-and-safety-of-a-covid-19-vaccine-in-south-african-adults-128423https://curecurrent.com/trials/evaluation-of-measurement-of-maternal-viral-load-at-delivery-to-optimise-post-natal-prophylaxis-of-hiv-exposed-newborns-128424https://curecurrent.com/trials/prevalence-and-longitudinal-follow-up-of-anal-lesions-hpv-infection-and-associated-sexually-transmitted-infections-among-128425https://curecurrent.com/trials/evaluation-of-triage-options-after-hpv-testing-for-cervical-cancer-screening-among-hiv-infected-women-128426https://curecurrent.com/trials/non-invasive-oral-cancer-screening-among-hiv-infected-individuals-128427https://curecurrent.com/trials/evaluating-strategies-to-reduce-mother-to-child-transmission-of-hiv-infection-in-resource-limited-countries-128428https://curecurrent.com/trials/zinc-supplementation-and-cardiovascular-risk-in-hiv-128429https://curecurrent.com/trials/darunavir-ritonavir-and-rosuvastatin-pharmacokinetic-study-128430https://curecurrent.com/trials/neurocognitive-effects-of-opiate-agonist-treatment-128431https://curecurrent.com/trials/non-inferiority-trial-of-locally-manufactured-hepa-b-vaccine-in-bangladesh-128432https://curecurrent.com/trials/combination-therapy-with-3bnc117-and-10-1074-in-hiv-infected-individuals-128433https://curecurrent.com/trials/safety-and-immunogenicity-of-oxford-astrazeneca-vaccine-against-covid-19-infection-128434https://curecurrent.com/trials/lenalidomide-in-treating-patients-with-aids-associated-kaposi-s-sarcoma-128435https://curecurrent.com/trials/sulforaphane-use-to-effect-inflammatory-and-metabolic-changes-in-virally-suppressed-hiv-patients-128436https://curecurrent.com/trials/dyadic-based-diagnosis-care-and-prevention-for-hiv-discordant-couples-in-tanzania-128437https://curecurrent.com/trials/imiquimod-5-cream-in-the-treatment-of-external-genital-or-perianal-warts-in-hiv-patients-128438https://curecurrent.com/trials/evaluating-hiv-1-neutralization-antibody-breadth-in-response-to-hiv-gp120-protein-vaccine-in-hiv-uninfected-adults-with-128439https://curecurrent.com/trials/propositive-protecting-positive-people-from-meningococcal-infection-follow-up-study-128440https://curecurrent.com/trials/pharmacokinetics-and-metabolism-of-14-carbon-14c-gsk3640254-128441https://curecurrent.com/trials/second-line-switch-to-dolutegravir-study-128442https://curecurrent.com/trials/evaluating-the-safety-tolerability-and-pharmacokinetics-of-bedaquiline-and-delamanid-alone-and-in-combination-for-drug-r-128443https://curecurrent.com/trials/impact-of-valganciclovir-on-severe-iris-kaposi-sarcoma-mortality-an-open-label-parallel-randomized-controlled-trial-128444https://curecurrent.com/trials/advancing-dignity-health-and-optimism-in-connection-with-long-acting-injectables-128445https://curecurrent.com/trials/pharmacogenetics-guided-isoniazid-dosing-in-tb-hiv-128446https://curecurrent.com/trials/fujilam-prospective-evaluation-trial-128447https://curecurrent.com/trials/pilot-study-of-effect-of-kaletra-on-cd4-response-in-hiv-positive-patients-with-viral-suppression-kimbo-study-128448https://curecurrent.com/trials/phase-ib-study-of-safety-tolerability-and-pharmacokinetics-of-elpida-once-weekly-in-healthy-volunteers-128449https://curecurrent.com/trials/non-interventional-observational-retrospective-study-to-evaluate-doravirine-based-regimens-in-hiv-infected-aged-patients-128450https://curecurrent.com/trials/diet-gut-microbiome-interaction-and-influence-on-inflammatory-disease-in-hiv-patients-128451https://curecurrent.com/trials/a-prospective-longitudinal-study-of-endothelial-function-in-hiv-hcv-coinfected-subjects-128452https://curecurrent.com/trials/a-peer-based-mobile-health-intervention-to-increase-access-adherence-to-hepatitis-c-treatment-hiv-viral-suppression-128453https://curecurrent.com/trials/heart-to-haart-smartphone-intervention-to-improve-haart-adherence-for-drug-users-128454https://curecurrent.com/trials/coronary-artery-disease-cad-in-patients-hiv-infected-128455https://curecurrent.com/trials/epoch-chemotherapy-il-12-for-previously-untreated-and-epoch-plus-rituximab-for-previously-treated-patients-with-aids-ass-128456https://curecurrent.com/trials/interferon-gamma-release-assays-in-tuberculosis-tb-hiv-co-infected-children-128457https://curecurrent.com/trials/diagnosis-of-tuberculosis-infection-in-hiv-co-infected-children-128458https://curecurrent.com/trials/prospective-cohort-study-of-hiv-and-zika-in-infants-and-pregnancy-128459https://curecurrent.com/trials/social-network-approach-for-increasing-testing-coverage-among-men-who-have-sex-with-men-128460https://curecurrent.com/trials/switching-to-a-fixed-dose-combination-of-bictegravir-emtricitabine-tenofovir-alafenamide-b-f-taf-in-human-immunodeficien-128461https://curecurrent.com/trials/open-labelled-randomized-study-to-evaluate-the-efficacy-safety-and-dose-selection-of-vm-1500a-lai-drug-in-hiv-infected-p-128462https://curecurrent.com/trials/a-combination-hiv-prevention-strategy-for-young-women-at-risk-for-hiv-128463https://curecurrent.com/trials/intervention-to-improve-engagement-in-care-among-newly-diagnosed-hiv-positive-men-128464https://curecurrent.com/trials/the-effect-of-ixazomib-on-the-latent-hiv-reservoir-128465https://curecurrent.com/trials/taste-properties-of-atazanavir-and-cobicistat-128466https://curecurrent.com/trials/evaluating-the-safety-and-pharmacokinetics-of-maraviroc-in-hiv-1-exposed-infants-at-risk-of-acquiring-hiv-1-infection-128467https://curecurrent.com/trials/prep-and-consumptions-128468https://curecurrent.com/trials/mystyle-online-family-based-hiv-prevention-for-non-heterosexual-black-adolescent-males-in-the-south-128469https://curecurrent.com/trials/increasing-uptake-of-evidence-based-screening-services-through-chw-led-multi-modality-intervention-128470https://curecurrent.com/trials/tushirikiane-hiv-self-testing-intervention-with-urban-refugee-youth-in-kampala-uganda-128471https://curecurrent.com/trials/quantification-of-immune-cells-in-women-using-contraception-chic-ii-128472https://curecurrent.com/trials/expression-of-ifn-epsilon-in-the-female-reproductive-tract-128473https://curecurrent.com/trials/pharmacokinetic-study-to-evaluate-double-dose-levonorgestrel-emergency-contraception-in-combination-with-efavirenz-based-128474https://curecurrent.com/trials/efficacy-and-safety-of-low-dose-colchicine-on-surrogate-markers-of-cardiovascular-events-in-people-living-with-hiv-recei-128475https://curecurrent.com/trials/a-drug-drug-interaction-study-of-shr2150-on-healthy-chinese-volunteers-128476https://curecurrent.com/trials/measuring-and-monitoring-adherence-to-art-with-pill-ingestible-sensor-system-128477https://curecurrent.com/trials/hush-restriction-in-hiv-infected-patients-128478https://curecurrent.com/trials/hepatitis-c-treatment-study-in-myanmar-128479https://curecurrent.com/trials/estrogen-probiotics-and-vaginal-health-to-prevent-hiv-infection-in-acb-women-128480https://curecurrent.com/trials/a-safety-and-immunogenicity-trial-of-ihv01-128481https://curecurrent.com/trials/support-for-perinatal-adherence-and-depression-128482https://curecurrent.com/trials/trauma-informed-prevention-for-substance-use-and-risky-sex-128483https://curecurrent.com/trials/study-to-evaluate-efficacy-and-safety-of-darunavir-cobicistat-emtricitabine-tenofovir-alafenamide-d-c-f-taf-regimen-vers-128484https://curecurrent.com/trials/cctg-594-engagement-and-retention-in-care-for-hiv-128485https://curecurrent.com/trials/diagnosis-of-pulmonary-tuberculosis-through-human-breath-tbenose-128486https://curecurrent.com/trials/study-to-assess-switching-to-b-f-taf-in-treatment-experienced-people-with-hiv-who-are-at-least-65-years-of-age-128487https://curecurrent.com/trials/the-treatment-ambassador-program-a-pilot-intervention-to-increase-treatment-initiation-128488https://curecurrent.com/trials/improving-prognosis-in-hiv-infection-128489https://curecurrent.com/trials/the-prevention-options-for-women-evaluation-research-power-cohort-128490https://curecurrent.com/trials/partners-prep-program-128491https://curecurrent.com/trials/study-to-assess-safety-and-activity-of-combination-therapy-of-vrc07-523ls-and-vorinostat-on-hiv-infected-persons-128492https://curecurrent.com/trials/hcv-hbv-hiv-testing-during-consultation-with-anesthesiologist-128493https://curecurrent.com/trials/retention-in-prep-care-for-african-american-msm-in-mississippi-128494https://curecurrent.com/trials/neuroinflammation-and-neurodegeneration-in-hiv-positive-subjects-switched-and-initially-treated-with-insti-128495https://curecurrent.com/trials/ambispective-cohort-study-to-evaluate-the-efficacy-safety-and-tolerance-of-an-antiretroviral-regimen-with-doravirine-128496https://curecurrent.com/trials/study-of-mdw-levels-predicting-the-development-of-sepsis-in-hospitalized-hiv-infected-patients-and-correlation-with-prog-128497https://curecurrent.com/trials/sava-syndemic-risk-reduction-for-african-american-couples-128498https://curecurrent.com/trials/erythropoietin-for-anemia-due-to-zidovudine-in-human-immunodeficiency-virus-infection-128499https://curecurrent.com/trials/yathu-yathu-an-impact-evaluation-of-community-based-peer-led-sexual-and-reproductive-health-services-128500https://curecurrent.com/trials/randomised-study-of-interferon-free-treatment-for-recently-acquired-hepatitis-c-in-pwid-and-people-with-hiv-coinfection-128501https://curecurrent.com/trials/pharmacokinetics-safety-and-efficacy-of-dolutegravir-dispersible-tablets-in-young-children-living-with-hiv-128502https://curecurrent.com/trials/optimized-antiretroviral-therapy-during-allogeneic-hematopoietic-stem-cell-transplantation-in-hiv-1-individuals-128503https://curecurrent.com/trials/evaluation-of-a-computer-based-system-using-cell-phones-for-hiv-people-in-peru-128504https://curecurrent.com/trials/safety-and-efficacy-of-fixed-dose-combination-dolutegravir-abacavir-lamivudine-fdc-initiated-during-acute-hiv-infection-128505https://curecurrent.com/trials/optimizing-the-delivery-of-hiv-npep-128506https://curecurrent.com/trials/arthrospira-platensis-as-nutrition-supplementation-for-female-adult-patients-infected-by-hiv-in-yaound-cameroon-128507https://curecurrent.com/trials/supplementation-trial-of-koko-plus-among-hiv-exposed-children-in-accra-128508https://curecurrent.com/trials/employing-esbi-in-hiv-testing-for-at-risk-youth-128509https://curecurrent.com/trials/a-community-based-implementation-model-for-hiv-prevention-and-testing-in-malawi-128510https://curecurrent.com/trials/text-messaging-intervention-to-improve-art-adherence-among-hiv-positive-youth-128511https://curecurrent.com/trials/evaluating-the-acceptability-and-uptake-of-pre-exposure-prophylaxis-prep-for-adolescent-women-in-the-deep-south-128512https://curecurrent.com/trials/antiretroviral-treatment-outcomes-in-hiv-hbv-co-infected-patients-in-southern-africa-128513https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-of-dna-mva-vaccines-in-hiv-1-infected-young-adults-taking-anti-hiv-medications-128514https://curecurrent.com/trials/pharmacokinetics-of-two-intravaginal-rings-ivrs-containing-different-dose-strengths-of-vicriviroc-mk-4176-and-mk-2048-128515https://curecurrent.com/trials/a-pilot-trial-of-perinatal-depression-treatment-in-hiv-infected-women-128516https://curecurrent.com/trials/inflammation-viral-replication-and-atherosclerosis-in-treated-hiv-infection-128517https://curecurrent.com/trials/safety-and-pharmacokinetic-study-of-fixed-dose-combination-of-zidovudine-lamivudine-and-nevirapine-in-hiv-infected-child-128518https://curecurrent.com/trials/safety-of-and-immune-response-to-an-hiv-1-vaccine-vrc-hivdna016-00-vp-and-a-vaccine-booster-vrc-hivadv014-00-vp-in-hiv-u-128519https://curecurrent.com/trials/blood-levels-of-anti-hiv-drugs-used-in-combination-regimens-in-hiv-infected-children-128520https://curecurrent.com/trials/safety-and-activity-of-the-oral-hiv-entry-inhibitor-amd11070-in-hiv-infected-patients-128521https://curecurrent.com/trials/monitoring-of-covid-19-vaccine-response-in-organ-transplant-patients-128522https://curecurrent.com/trials/effectiveness-of-and-immune-response-to-hiv-vaccination-followed-by-treatment-interruption-in-hiv-infected-patients-128523https://curecurrent.com/trials/pegylated-interferon-alfa-2a-maintenance-therapy-and-liver-disease-progression-in-people-infected-with-both-hiv-and-hepa-128524https://curecurrent.com/trials/buffergel-and-pro-2000-5-vaginal-gels-to-prevent-hiv-infection-in-women-128525https://curecurrent.com/trials/allogeneic-hematopoietic-stem-cell-transplantation-in-hiv-1-infected-patients-128526https://curecurrent.com/trials/dual-therapy-in-hiv-patients-in-4-days-a-week-versus-7-days-a-week-128527https://curecurrent.com/trials/evaluating-the-safety-and-pharmacokinetics-of-raltegravir-in-infants-128528https://curecurrent.com/trials/safety-and-effectiveness-of-emtricitabine-efavirenz-and-didanosine-in-hiv-infected-children-who-have-taken-few-or-no-ant-128529https://curecurrent.com/trials/atazanavir-used-in-combination-with-other-anti-hiv-drugs-in-hiv-infected-infants-children-and-adolescents-128530https://curecurrent.com/trials/a-safety-and-immune-response-study-of-2-experimental-hiv-vaccines-128531https://curecurrent.com/trials/a-phase-ii-iii-trial-of-lopinavir-ritonavir-dosed-according-to-the-who-pediatric-weight-band-dosing-guidelines-128532https://curecurrent.com/trials/safety-and-immune-response-to-vicriviroc-in-combination-regimens-in-hiv-infected-art-experienced-children-and-adolescent-128533https://curecurrent.com/trials/assessment-of-pre-exposure-prophylaxis-prep-administered-at-sexually-transmitted-disease-std-clinics-128534https://curecurrent.com/trials/safety-tolerance-and-pharmacokinetics-of-raltegravir-containing-antiretroviral-therapy-in-infants-children-infected-with-128535https://curecurrent.com/trials/an-international-study-to-evaluate-recombinant-interleukin-2-in-hiv-positive-patients-taking-anti-retroviral-therapy-128536https://curecurrent.com/trials/evaluating-the-safety-of-immediate-versus-deferred-isoniazid-preventive-therapy-among-hiv-infected-pregnant-women-128537https://curecurrent.com/trials/preventing-sexual-transmission-of-hiv-with-anti-hiv-drugs-128538https://curecurrent.com/trials/evaluating-the-safety-and-tolerability-of-antiretroviral-drug-regimens-used-as-pre-exposure-prophylaxis-to-prevent-hiv-i-128539https://curecurrent.com/trials/safety-and-effectiveness-of-alendronate-for-bone-mineral-density-in-hiv-infected-children-and-adolescents-128540https://curecurrent.com/trials/safety-of-and-immune-response-to-an-h1n1-influenza-virus-vaccine-in-hiv-infected-children-and-youth-128541https://curecurrent.com/trials/safety-of-and-immune-response-to-a-novel-human-papillomavirus-vaccine-in-hiv-infected-children-128542https://curecurrent.com/trials/evaluating-the-safety-tolerability-and-effect-of-a-human-monoclonal-antibody-vrc01-on-markers-of-hiv-persistence-in-hiv-128543https://curecurrent.com/trials/reducing-the-incidence-of-nevirapine-resistance-mutations-in-pregnant-hiv-infected-women-who-receive-anti-hiv-drugs-prio-128544https://curecurrent.com/trials/safety-and-immune-response-of-bms-936559-in-hiv-infected-people-taking-combination-antiretroviral-therapy-128545https://curecurrent.com/trials/safety-of-and-immune-response-to-an-h1n1-influenza-vaccine-in-hiv-infected-pregnant-women-128546https://curecurrent.com/trials/safety-and-immune-response-of-a-rotavirus-vaccine-in-hiv-infected-and-uninfected-children-born-to-hiv-infected-mothers-128547https://curecurrent.com/trials/drug-treatment-combined-with-drug-and-risk-reduction-counseling-to-prevent-of-hiv-infection-and-death-among-injection-dr-128548https://curecurrent.com/trials/safety-and-pharmacokinetics-of-raltegravir-in-hiv-1-exposed-newborn-infants-at-risk-of-acquiring-hiv-1-infection-128549https://curecurrent.com/trials/anti-hiv-drug-regimens-and-treatment-switching-guidelines-in-hiv-infected-children-128550https://curecurrent.com/trials/a-study-of-foscarnet-plus-ganciclovir-in-the-treatment-of-cytomegalovirus-of-the-eye-in-patients-with-aids-who-have-alre-128551https://curecurrent.com/trials/a-study-of-zidovudine-plus-interleukin-2-in-hiv-infected-patients-who-have-no-symptoms-of-infection-but-who-have-tender-128552https://curecurrent.com/trials/the-safety-and-effectiveness-of-methylprednisolone-in-the-treatment-of-pneumocystis-carinii-pneumonia-pcp-in-children-wi-128553https://curecurrent.com/trials/a-study-of-ganciclovir-in-the-treatment-of-cytomegalovirus-of-the-eyes-128554https://curecurrent.com/trials/a-phase-i-safety-efficacy-and-pharmacokinetic-study-of-2-3-dideoxyinosine-ddi-administered-twice-daily-to-patients-with-128555https://curecurrent.com/trials/a-study-of-141w94-used-alone-or-in-combination-with-zidovudine-plus-3tc-in-hiv-infected-patients-128556https://curecurrent.com/trials/a-phase-iii-randomized-trial-of-topical-vaginal-fluorouracil-5-fluorouracil-5-fu-maintenance-therapy-versus-observation-128557https://curecurrent.com/trials/a-placebo-controlled-phase-i-pilot-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-env-2-3-a-yeast-derived-r-128558https://curecurrent.com/trials/a-phase-i-multicenter-randomized-double-blind-placebo-controlled-hiv-1-vaccine-trial-to-evaluate-the-safety-and-immunoge-128559https://curecurrent.com/trials/live-zoster-vaccine-in-hiv-infected-adults-on-antiretroviral-therapy-128560https://curecurrent.com/trials/treatment-with-combinations-of-several-antiviral-drugs-in-infants-and-young-children-with-hiv-infection-128561https://curecurrent.com/trials/brief-rifapentine-isoniazid-evaluation-for-tb-prevention-brief-tb-128562https://curecurrent.com/trials/a-comparison-of-three-treatments-for-advanced-hiv-disease-in-patients-who-have-received-nucleoside-therapy-in-the-past-128563https://curecurrent.com/trials/a-phase-ii-double-blind-trial-of-recombinant-human-nerve-growth-factor-for-treatment-of-hiv-associated-sensory-neuropath-128564https://curecurrent.com/trials/a-phase-i-multicenter-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-vaccinia-derived-hiv-1-recombinant-env-128565https://curecurrent.com/trials/the-safety-and-effectiveness-of-ganciclovir-used-alone-or-in-combination-with-granulocyte-macrophage-colony-stimulating-128566https://curecurrent.com/trials/a-phase-i-clinical-trial-to-evaluate-part-a-the-safety-of-mtp-pe-mf59-adjuvant-emulsion-part-b-the-safety-and-immunogeni-128567https://curecurrent.com/trials/gradual-initiation-of-sulfamethoxazole-trimethoprim-as-primary-pneumocystis-carinii-pneumonia-prophylaxis-128568https://curecurrent.com/trials/a-randomized-comparative-trial-of-zidovudine-azt-versus-2-3-didehydro-3-deoxythymidine-stavudine-d4t-in-children-with-hi-128569https://curecurrent.com/trials/a-phase-i-ii-study-of-delayed-type-hypersensitivity-dth-reactions-to-intradermal-hiv-envelope-antigen-128570https://curecurrent.com/trials/comparison-of-two-dosage-regimens-of-oral-dapsone-for-prophylaxis-of-pneumocystis-carinii-pneumonia-in-pediatric-hiv-inf-128571https://curecurrent.com/trials/a-comparative-study-of-a-combination-of-zidovudine-didanosine-and-double-blinded-nevirapine-versus-a-combination-of-zido-128572https://curecurrent.com/trials/a-study-of-tumor-necrosis-factor-and-human-interferon-gamma-in-patients-with-aids-related-complex-128573https://curecurrent.com/trials/a-phase-i-multicenter-randomized-trial-to-evaluate-the-safety-and-immunogenicity-of-a-recombinant-vaccinia-hiv-envelope-128574https://curecurrent.com/trials/randomized-phase-i-ii-dose-ranging-open-label-trial-of-the-anti-hiv-activity-of-delavirdine-mesylate-dlv-u-90-152s-128575https://curecurrent.com/trials/adding-maraviroc-or-metformin-for-hepatic-steatosis-in-people-living-with-hiv-128576https://curecurrent.com/trials/a-study-of-zidovudine-plus-acyclovir-in-hiv-infected-patients-128577https://curecurrent.com/trials/evaluating-the-effectiveness-of-boceprevir-pegylated-interferon-alfa-2b-and-ribavirin-in-treating-hepatitis-c-virus-hcv-128578https://curecurrent.com/trials/a-randomized-comparative-study-of-daily-dapsone-and-daily-atovaquone-for-prophylaxis-against-pcp-in-hiv-infected-patient-128579https://curecurrent.com/trials/combination-pain-therapy-in-hiv-neuropathy-128580https://curecurrent.com/trials/a-study-of-foscarnet-in-the-treatment-of-hiv-infection-in-patients-who-have-taken-zidovudine-for-a-long-time-128581https://curecurrent.com/trials/study-of-four-different-treatment-approaches-for-patients-who-have-mycobacterium-avium-complex-disease-mac-plus-aids-128582https://curecurrent.com/trials/a-study-of-azt-in-hiv-infected-patients-with-aids-related-kaposi-s-sarcoma-128583https://curecurrent.com/trials/a-study-of-zidovudine-in-hiv-infected-patients-with-liver-disease-128584https://curecurrent.com/trials/a-study-of-itraconazole-in-the-treatment-and-prevention-of-histoplasmosis-a-fungal-infection-in-patients-with-aids-128585https://curecurrent.com/trials/safety-tolerability-and-immune-response-to-lc002-an-experimental-therapeutic-vaccine-in-adults-receiving-haart-128586https://curecurrent.com/trials/a-randomized-comparative-pharmacokinetic-study-of-oral-ganciclovir-after-treatment-with-intravenous-ganciclovir-for-cyto-128587https://curecurrent.com/trials/effectiveness-of-palifermin-in-increasing-cd4-counts-in-treatment-experienced-hiv-infected-adults-128588https://curecurrent.com/trials/immunologic-and-virologic-consequences-of-long-term-highly-active-antiretroviral-therapy-haart-in-subjects-with-moderate-128589https://curecurrent.com/trials/a-study-of-foscarnet-in-the-treatment-of-cytomegalovirus-cmv-of-the-eyes-in-patients-with-aids-who-cannot-use-ganciclovi-128590https://curecurrent.com/trials/the-safety-and-effectiveness-of-human-monoclonal-antibody-f105-in-the-treatment-of-hiv-128591https://curecurrent.com/trials/a-phase-i-multicenter-randomized-double-blind-placebo-controlled-trial-to-evaluate-the-safety-and-immunogenicity-of-hiv-128592https://curecurrent.com/trials/escalating-multiple-dose-safety-and-tolerance-of-wr-6026-hydrochloride-in-hiv-infected-subjects-128593https://curecurrent.com/trials/a-randomized-placebo-controlled-double-blinded-phase-i-safety-and-immunogenicity-trial-of-recombinant-envelope-protein-h-128594https://curecurrent.com/trials/a-phase-i-multicenter-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-vaccinia-derived-hiv-1-recombinant-env-128595https://curecurrent.com/trials/granulocyte-macrophage-colony-stimulating-factor-and-zidovudine-a-phase-i-study-of-concurrent-administration-in-patients-128596https://curecurrent.com/trials/a-comparison-of-zidovudine-azt-used-alone-or-in-combination-with-didanosine-ddi-or-dideoxycytidine-ddc-in-hiv-infected-p-128597https://curecurrent.com/trials/methadone-effects-on-zidovudine-zdv-azt-disposition-128598https://curecurrent.com/trials/the-safety-and-effectiveness-of-ganciclovir-in-the-prevention-of-cytomegalovirus-cmv-of-the-eyes-and-disease-of-the-stom-128599https://curecurrent.com/trials/high-dose-fluconazole-for-the-treatment-of-cryptococcal-meningitis-in-hiv-infected-individuals-128600https://curecurrent.com/trials/effectiveness-of-azt-and-nevirapine-in-preventing-hiv-transmission-from-ugandan-mothers-to-their-newborns-128601https://curecurrent.com/trials/a-phase-i-multicenter-trial-to-evaluate-the-safety-and-immunogenicity-of-hiv-1-recombinant-envelope-glycoprotein-gp160-128602https://curecurrent.com/trials/a-phase-i-concentration-controlled-trial-to-assess-the-safety-tolerance-pharmacokinetics-and-development-of-decreased-hi-128603https://curecurrent.com/trials/a-randomized-phase-ii-study-of-two-doses-of-interferon-alfa-2a-ifn-alfa-2a-in-combination-with-zidovudine-azt-and-dideox-128604https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-live-recombinant-canarypox-alvac-hiv-vcp205-and-hiv-1-sf-2-rgp120-in-hiv-1-128605https://curecurrent.com/trials/comparison-of-foscarnet-versus-vidarabine-in-the-treatment-of-herpes-infection-in-patients-with-aids-who-have-not-had-su-128606https://curecurrent.com/trials/randomized-double-blind-placebo-controlled-trial-of-nimodipine-for-the-neurological-manifestations-of-hiv-1-128607https://curecurrent.com/trials/the-effectiveness-of-three-drug-combinations-in-hiv-infected-patients-who-have-taken-zidovudine-for-more-than-12-weeks-128608https://curecurrent.com/trials/interactions-of-hiv-protease-inhibitors-and-methadone-in-hiv-infected-patients-128609https://curecurrent.com/trials/effects-of-a-uridine-supplement-on-hiv-infected-adults-with-lipoatrophy-128610https://curecurrent.com/trials/optimizing-treatment-for-treatment-experienced-hiv-infected-people-128611https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-study-of-hiv-p17-p24-ty-vlp-in-hiv-1-seronegative-subjects-128612https://curecurrent.com/trials/a-phase-i-study-to-evaluate-the-safety-and-immunogenicity-of-recombinant-hiv-1-envelope-antigen-in-children-born-to-hiv-128613https://curecurrent.com/trials/the-safety-and-effectiveness-of-valacyclovir-hcl-in-the-treatment-of-herpes-simplex-or-varicella-zoster-infections-in-hi-128614https://curecurrent.com/trials/the-effectiveness-of-ritonavir-plus-zidovudine-plus-lamivudine-in-hiv-infected-patients-128615https://curecurrent.com/trials/the-treatment-of-tuberculosis-in-hiv-infected-patients-128616https://curecurrent.com/trials/a-study-of-several-anti-hiv-drug-combinations-in-hiv-infected-patients-who-have-used-indinavir-128617https://curecurrent.com/trials/a-phase-i-ii-trial-of-vaccine-therapy-of-hiv-1-infected-individuals-with-50-500-cd4-cells-mm3-128618https://curecurrent.com/trials/a-phase-i-multicenter-randomized-trial-to-evaluate-the-safety-and-immunogenicity-of-vaccinia-derived-mn-hiv-1-recombinan-128619https://curecurrent.com/trials/charlotte-retention-in-care-study-128620https://curecurrent.com/trials/a-study-of-azt-plus-ganciclovir-in-patients-with-aids-and-cytomegalovirus-cmv-infection-128621https://curecurrent.com/trials/antiviral-activity-of-and-resistance-to-lamivudine-in-combination-with-zidovudine-stavudine-or-didanosine-128622https://curecurrent.com/trials/a-study-of-chemotherapy-plus-azidothymidine-in-the-treatment-of-kaposi-s-sarcoma-in-patients-with-aids-128623https://curecurrent.com/trials/a-prospective-randomized-open-label-comparative-trial-of-dideoxyinosine-ddi-versus-dideoxycytidine-ddc-in-hiv-infected-p-128624https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-live-recombinant-canarypox-alvac-hiv-vcp205-in-hiv-1-uninfected-adult-volun-128625https://curecurrent.com/trials/virologic-responses-to-new-nucleoside-regimens-after-prolonged-zdv-or-ddi-monotherapy-128626https://curecurrent.com/trials/comparison-of-new-anti-hiv-drug-combinations-in-hiv-infected-children-who-have-taken-anti-hiv-drugs-128627https://curecurrent.com/trials/a-phase-i-study-of-safety-and-pharmacokinetics-of-nevirapine-in-hiv-1-infected-pregnant-women-and-neonates-born-to-hiv-1-128628https://curecurrent.com/trials/a-double-blind-placebo-controlled-trial-of-paromomycin-for-treatment-of-cryptosporidiosis-in-patients-with-advanced-hiv-128629https://curecurrent.com/trials/comparison-of-three-anti-hiv-regimens-to-prevent-nevirapine-resistance-in-women-who-take-nevirapine-during-pregnancy-128630https://curecurrent.com/trials/thalidomide-for-treatment-of-oral-and-esophageal-aphthous-ulcers-and-hiv-viremia-in-patients-with-hiv-infection-128631https://curecurrent.com/trials/a-multi-center-clinical-trial-to-evaluate-azidothymidine-azt-in-the-treatment-of-human-immunodeficiency-virus-hiv-infect-128632https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-live-recombinant-canarypox-gp160-mn-alvac-vcp125-hiv-1-gp160-mn-in-hiv-1-un-128633https://curecurrent.com/trials/the-anti-hiv-effects-of-saquinavir-soft-gelatin-capsules-versus-indinavir-in-patients-who-have-used-saquinavir-hard-gela-128634https://curecurrent.com/trials/safety-and-effectiveness-of-four-anti-hiv-drug-combinations-in-hiv-infected-children-and-teens-128635https://curecurrent.com/trials/a-study-of-three-drugs-plus-zidovudine-in-the-prevention-of-infections-in-hiv-infected-patients-128636https://curecurrent.com/trials/a-study-of-dideoxycytidine-in-hiv-infected-patients-128637https://curecurrent.com/trials/a-study-of-stem-cells-and-filgrastim-128638https://curecurrent.com/trials/a-phase-i-multicenter-randomized-double-blind-placebo-controlled-hiv-1-vaccine-trial-to-evaluate-the-safety-and-immunoge-128639https://curecurrent.com/trials/prophylaxis-against-tuberculosis-tb-in-patients-with-human-immunodeficiency-virus-hiv-infection-and-suspected-latent-tub-128640https://curecurrent.com/trials/a-study-of-disease-progression-and-anti-hiv-treatments-128641https://curecurrent.com/trials/a-phase-i-multicenter-randomized-trial-to-evaluate-the-safety-and-immunogenicity-of-a-recombinant-vaccinia-hiv-envelope-128642https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-live-recombinant-canarypox-alvac-hiv-vcp205-and-hiv-1-sf-2-rgp120-in-hiv-1-128643https://curecurrent.com/trials/cyclosporine-a-in-combination-with-abacavir-sulfate-lamivudine-and-zidovudine-and-lopinavir-ritonavir-in-hiv-128644https://curecurrent.com/trials/a-phase-i-multicenter-randomized-double-blind-placebo-controlled-trial-to-evaluate-the-safety-and-immunogenicity-of-hiv-128645https://curecurrent.com/trials/safety-and-effectiveness-of-anti-hiv-vaccines-in-hiv-negative-adults-128646https://curecurrent.com/trials/the-safety-and-effectiveness-of-injections-of-human-recombinant-interferon-gamma-in-patients-with-aids-who-have-taken-zi-128647https://curecurrent.com/trials/study-to-explore-natural-daily-variation-and-impact-of-stress-in-hiv-levels-128648https://curecurrent.com/trials/the-safety-and-effectiveness-of-zidovudine-in-the-treatment-of-patients-with-early-aids-related-complex-128649https://curecurrent.com/trials/the-safety-and-effectiveness-of-interleukin-2-plus-zidovudine-in-patients-with-aids-or-aids-related-complex-128650https://curecurrent.com/trials/a-randomized-double-blind-four-arm-study-comparing-combination-nucleoside-alternating-nucleoside-and-triple-drug-therapy-128651https://curecurrent.com/trials/a-phase-i-comparative-blinded-trial-of-several-hiv-1-derived-immunogens-in-infected-individuals-with-500-cd4-cells-mm3-128652https://curecurrent.com/trials/a-study-of-azt-plus-human-interferon-alpha-in-the-treatment-of-aids-related-kaposi-s-sarcoma-128653https://curecurrent.com/trials/safety-and-effectiveness-of-giving-isotretinoin-to-hiv-infected-women-to-treat-cervical-tumors-128654https://curecurrent.com/trials/effect-of-intermittent-aldesleukin-treatment-with-or-without-anti-hiv-drugs-in-hiv-infected-people-128655https://curecurrent.com/trials/a-study-of-dideoxycytidine-plus-zidovudine-azt-in-hiv-infected-children-who-have-taken-azt-128656https://curecurrent.com/trials/a-study-of-three-anti-hiv-drug-combinations-in-patients-who-have-taken-amprenavir-128657https://curecurrent.com/trials/comparison-of-trimetrexate-plus-leucovorin-calcium-rescue-versus-sulfamethoxazole-trimethoprim-in-the-treatment-of-pneum-128658https://curecurrent.com/trials/the-safety-and-effectiveness-of-hyperimmune-anti-hiv-intravenous-immunoglobulin-hvig-plus-zidovudine-in-hiv-infected-inf-128659https://curecurrent.com/trials/a-phase-i-ii-study-of-hyperimmune-ivig-in-slowing-progression-of-disease-in-hiv-infected-children-128660https://curecurrent.com/trials/comparison-of-three-anti-hiv-drug-combinations-in-hiv-infected-patients-with-no-symptoms-of-the-disease-128661https://curecurrent.com/trials/a-phase-ii-double-blind-study-of-delavirdine-mesylate-u-90152-in-combination-with-zidovudine-azt-and-or-didanosine-ddi-v-128662https://curecurrent.com/trials/effect-of-addition-of-raltegravir-mk-0518-to-pi-or-nnrti-based-art-regimens-in-hiv-infected-subjects-with-undetectable-v-128663https://curecurrent.com/trials/a-multicenter-double-blind-comparative-study-of-zidovudine-alone-versus-zidovudine-and-acyclovir-as-treatment-for-hiv-in-128664https://curecurrent.com/trials/safety-of-and-immune-response-to-the-human-papillomavirus-hpv-vaccine-in-hiv-infected-women-128665https://curecurrent.com/trials/the-safety-of-different-dose-levels-of-zidovudine-in-hiv-infected-children-128666https://curecurrent.com/trials/a-phase-i-multicenter-randomized-double-blind-placebo-controlled-hiv-1-vaccine-trial-to-evaluate-the-safety-and-immunoge-128667https://curecurrent.com/trials/comparison-of-stavudine-used-alone-or-in-combination-with-didanosine-in-hiv-infected-children-128668https://curecurrent.com/trials/a-phase-i-multicenter-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-vaccinia-derived-hiv-1-recombinant-env-128669https://curecurrent.com/trials/a-phase-ii-clinical-trial-to-evaluate-the-immunogenicity-and-reactogenicity-of-the-recombinant-hiv-1-envelope-vaccines-s-128670https://curecurrent.com/trials/a-study-of-pyrimethamine-in-the-treatment-of-infection-by-a-certain-parasite-in-hiv-positive-patients-128671https://curecurrent.com/trials/a-randomized-comparative-prospective-study-of-daily-trimethoprim-sulfamethoxazole-tms-and-thrice-weekly-tms-for-prophyla-128672https://curecurrent.com/trials/trimetrexate-plus-leucovorin-calcium-rescue-versus-sulfamethoxazole-trimethoprim-in-the-treatment-of-pneumocystis-carini-128673https://curecurrent.com/trials/a-study-to-compare-different-drugs-used-to-prevent-serious-bacterial-infections-in-hiv-positive-children-128674https://curecurrent.com/trials/a-phase-i-concentration-targeted-multidose-study-of-atevirdine-mesylate-u-87201e-azt-and-ddi-or-ddc-128675https://curecurrent.com/trials/a-phase-ii-safety-and-immunogenicity-trial-of-live-recombinant-canarypox-alvac-hiv-vcp205-with-or-without-hiv-1-sf-2-rgp-128676https://curecurrent.com/trials/the-safety-and-effectiveness-of-zidovudine-azt-in-the-treatment-of-hiv-infection-in-patients-with-aids-and-advanced-arc-128677https://curecurrent.com/trials/evaluating-the-safety-and-tolerability-of-ruxolitinib-in-antiretroviral-treated-hiv-infected-adults-128678https://curecurrent.com/trials/a-study-of-three-treatment-combinations-using-zidovudine-plus-lamivudine-plus-indinavir-in-hiv-infected-patients-128679https://curecurrent.com/trials/a-phase-i-multicenter-trial-to-evaluate-the-safety-and-immunogenicity-of-hiv-1-recombinant-envelope-glycoprotein-gp160-128680https://curecurrent.com/trials/a-phase-i-multicenter-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-vaccinia-derived-mn-hiv-1-recombinant-128681https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-live-recombinant-canarypox-alvac-hiv-vcp300-and-hiv-1-sf-2-rgp120-in-hiv-1-128682https://curecurrent.com/trials/a-phase-i-randomized-double-blind-placebo-controlled-clinical-trial-to-compare-the-safety-and-immunogenicity-of-recombin-128683https://curecurrent.com/trials/nitazoxanide-plus-ribavirin-and-peginterferon-for-therapy-of-treatment-naive-hcv-genotype-1-and-hiv-coinfected-subjects-128684https://curecurrent.com/trials/a-study-of-doxorubicin-in-the-treatment-of-aids-related-kaposi-s-sarcoma-128685https://curecurrent.com/trials/a-study-of-pentamidine-in-the-prevention-of-pneumocystis-carinii-pneumonia-128686https://curecurrent.com/trials/a-pharmacologically-guided-phase-i-ii-study-of-daily-orally-administered-synthetic-hypericin-in-hiv-infected-subjects-128687https://curecurrent.com/trials/active-immunization-of-asymptomatic-hiv-infected-individuals-with-recombinant-gp160-hiv-1-antigen-a-phase-i-ii-study-of-128688https://curecurrent.com/trials/evaluating-the-safety-and-effectiveness-of-interferon-free-treatment-of-hepatitis-c-virus-infection-in-hiv-coinfected-ad-128689https://curecurrent.com/trials/a-study-of-trimetrexate-in-the-treatment-of-pneumocystis-carinii-pneumonia-pcp-in-patients-with-aids-not-previously-trea-128690https://curecurrent.com/trials/a-study-of-indinavir-sulfate-plus-zidovudine-azt-plus-lamivudine-in-hiv-infected-patients-who-have-taken-azt-for-six-or-128691https://curecurrent.com/trials/a-phase-i-pharmacokinetic-and-tolerance-study-of-28-day-regimens-of-oral-ganciclovir-128692https://curecurrent.com/trials/a-trial-of-alternating-2-3-dideoxycytidine-and-zidovudine-in-the-treatment-of-patients-with-advanced-hiv-disease-128693https://curecurrent.com/trials/phase-i-pharmacokinetic-and-tolerance-study-of-ribavirin-in-human-immunodeficiency-virus-hiv-infected-patients-128694https://curecurrent.com/trials/a-multicenter-dose-ranging-clinical-trial-of-2-3-dideoxycytidine-in-the-treatment-of-patients-with-aids-and-advanced-arc-128695https://curecurrent.com/trials/the-efficacy-of-a-standardized-acupuncture-regimen-and-amitriptyline-compared-with-placebo-as-a-treatment-for-pain-cause-128696https://curecurrent.com/trials/a-randomized-unblinded-trial-of-zidovudine-versus-ddc-in-the-treatment-of-patients-status-post-pcp-who-received-long-ter-128697https://curecurrent.com/trials/a-phase-i-study-of-the-combination-of-recombinant-gm-csf-azt-and-chemotherapy-abv-adriamycin-bleomycin-vincristine-in-ai-128698https://curecurrent.com/trials/phase-i-study-of-weekly-oral-vp-16-for-aids-associated-kaposi-s-sarcoma-128699https://curecurrent.com/trials/a-phase-ii-dose-ranging-open-labelled-trial-of-foscarnet-salvage-therapy-for-aids-patients-with-sight-threatening-cmv-re-128700https://curecurrent.com/trials/chemotherapy-and-azidothymidine-with-or-without-radiotherapy-for-high-grade-lymphoma-in-aids-risk-group-members-128701https://curecurrent.com/trials/phase-ii-study-of-zidovudine-and-recombinant-alpha-2a-interferon-in-the-treatment-of-patients-with-aids-associated-kapos-128702https://curecurrent.com/trials/subcutaneously-administered-aldesleukin-interleukin-2-il-2-therapy-in-hiv-infected-patients-128703https://curecurrent.com/trials/a-controlled-comparative-trial-of-sulfamethoxazole-trimethoprim-versus-aerosolized-pentamidine-for-secondary-prophylaxis-128704https://curecurrent.com/trials/a-phase-iii-randomized-trial-of-low-dose-versus-standard-dose-mbacod-chemotherapy-with-rgm-csf-for-treatment-of-aids-ass-128705https://curecurrent.com/trials/a-phase-i-evaluation-of-azidothymidine-azt-in-children-with-acquired-immune-deficiency-syndrome-aids-or-aids-related-com-128706https://curecurrent.com/trials/a-phase-i-clinical-trial-to-evaluate-the-toxicity-antiviral-and-immunomodulatory-effects-of-a-range-of-doses-of-ampligen-128707https://curecurrent.com/trials/influence-of-probenecid-and-quinine-on-the-pharmacokinetics-of-azidothymidine-128708https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-azithromycin-on-mac-disease-prevention-in-hiv-positive-patients-128709https://curecurrent.com/trials/a-phase-ii-iii-trial-of-rifampin-ciprofloxacin-clofazimine-ethambutol-and-amikacin-in-the-treatment-of-disseminated-myco-128710https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-toxicity-and-antiviral-effects-of-a-range-of-doses-of-ampligen-in-p24-antigen-positive-128711https://curecurrent.com/trials/foscarnet-treatment-of-serious-cmv-retinitis-infection-in-patients-with-acquired-immunodeficiency-syndrome-128712https://curecurrent.com/trials/a-phase-i-dose-escalation-study-of-synthetic-hypericin-in-hiv-infected-patients-with-less-than-300-cd4-lymphocytes-128713https://curecurrent.com/trials/a-study-to-assess-the-effect-of-concomitant-administration-of-fluconazole-on-the-clinical-pharmacokinetics-of-methadone-128714https://curecurrent.com/trials/a-randomized-prospective-double-blind-study-comparing-fluconazole-with-placebo-for-primary-and-secondary-prophylaxis-of-128715https://curecurrent.com/trials/a-phase-i-study-of-tnp-470-in-the-treatment-of-aids-associated-kaposi-s-sarcoma-128716https://curecurrent.com/trials/comparison-of-three-treatments-for-pneumocystis-pneumonia-in-aids-patients-128717https://curecurrent.com/trials/hiv-prevention-among-at-risk-latinos-in-the-heartland-128718https://curecurrent.com/trials/a-controlled-trial-comparing-the-efficacy-of-aerosolized-pentamidine-and-parenteral-oral-sulfamethoxazole-trimethoprim-i-128719https://curecurrent.com/trials/a-phase-i-ii-open-label-study-to-evaluate-the-antiviral-potential-of-combination-zidovudine-and-2-3-dideoxyinosine-didan-128720https://curecurrent.com/trials/a-phase-i-ii-dose-escalation-study-of-intradermal-gp160-to-evaluate-safety-delayed-type-hypersensitivity-skin-test-respo-128721https://curecurrent.com/trials/safety-of-and-immune-response-to-a-meningitis-vaccine-in-hiv-infected-children-and-youth-128722https://curecurrent.com/trials/a-phase-iii-comparative-study-of-dapsone-trimethoprim-and-clindamycin-primaquine-versus-sulfamethoxazole-trimethoprim-in-128723https://curecurrent.com/trials/a-multicenter-prospective-randomized-double-blind-placebo-controlled-trial-of-three-preparations-of-low-dose-oral-alpha-128724https://curecurrent.com/trials/a-pharmacokinetic-and-tolerance-study-of-oral-ganciclovir-in-hiv-infected-children-with-asymptomatic-cytomegalovirus-inf-128725https://curecurrent.com/trials/safety-and-tolerance-of-zidovudine-with-probenecid-and-the-effect-of-probenecid-on-zidovudine-pharmacokinetics-over-four-128726https://curecurrent.com/trials/safety-and-efficacy-of-zidovudine-for-asymptomatic-hiv-infected-individuals-128727https://curecurrent.com/trials/continuous-high-dose-intravenous-dextran-sulfate-in-human-immunodeficiency-virus-infected-individuals-128728https://curecurrent.com/trials/a-double-blind-placebo-controlled-trial-to-evaluate-intravenous-gamma-globulin-in-children-with-symptomatic-hiv-infectio-128729https://curecurrent.com/trials/aerosols-in-the-treatment-of-pneumocystis-pneumonia-a-pilot-study-quantitating-the-deposition-of-aerosolized-pentamidine-128730https://curecurrent.com/trials/evaluation-of-the-interaction-between-acetaminophen-and-zidovudine-128731https://curecurrent.com/trials/a-multicenter-study-to-determine-foscarnet-dose-response-in-hiv-infected-patients-with-pgl-and-or-constitutional-disease-128732https://curecurrent.com/trials/a-prospective-study-of-multidrug-resistance-and-a-pilot-study-of-the-safety-of-and-clinical-and-microbiologic-response-t-128733https://curecurrent.com/trials/phase-i-ii-study-of-recombinant-human-interferon-gamma-rifn-gamma-in-hiv-infected-children-128734https://curecurrent.com/trials/comparison-of-2-3-dideoxyinosine-didanosine-ddi-and-zidovudine-in-therapy-of-patients-with-the-aids-dementia-complex-128735https://curecurrent.com/trials/a-phase-i-study-of-azt-and-human-interferon-alpha-recombinant-alpha-2a-and-lymphoblastoid-in-the-treatment-of-aids-assoc-128736https://curecurrent.com/trials/evaluation-of-the-safety-and-tolerance-of-immunotherapy-with-autologous-ex-vivo-expanded-hiv-specific-cytotoxic-t-cells-128737https://curecurrent.com/trials/immunogenicity-and-safety-of-a-third-dose-and-immune-persistence-of-bbibp-corv-vaccine-in-people-with-hiv-infected-128738https://curecurrent.com/trials/evaluation-of-the-interaction-between-low-dose-sulfamethoxazole-trimethoprim-and-zidovudine-128739https://curecurrent.com/trials/a-multicenter-placebo-controlled-double-blind-trial-to-evaluate-azidothymidine-azt-treatment-of-the-aids-dementia-comple-128740https://curecurrent.com/trials/safety-and-effectiveness-of-cd4-igg2-in-hiv-positive-children-128741https://curecurrent.com/trials/a-clinical-trial-of-alternating-and-intermittent-regimens-of-2-3-dideoxycytidine-and-3-azido-3-deoxythymidine-in-the-tre-128742https://curecurrent.com/trials/a-placebo-controlled-phase-i-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-recombinant-envelope-proteins-o-128743https://curecurrent.com/trials/phase-i-trial-of-the-combination-of-zidovudine-and-recombinant-interleukin-2-in-patients-with-persistent-generalized-lym-128744https://curecurrent.com/trials/a-phase-i-ii-open-label-study-to-evaluate-the-antiviral-potential-of-combination-low-dose-therapy-with-zidovudine-and-in-128745https://curecurrent.com/trials/a-randomized-double-blind-phase-ii-iii-trial-of-monotherapy-vs-combination-therapy-with-nucleoside-analogs-in-hiv-infect-128746https://curecurrent.com/trials/a-randomized-double-blind-comparative-study-of-dideoxycytidine-ddc-alone-or-ddc-azt-combination-versus-zidovudine-zdv-al-128747https://curecurrent.com/trials/emtricitabine-tenofovir-disoproxil-fumarate-for-hiv-prevention-in-men-128748https://curecurrent.com/trials/phase-i-trial-of-mbacod-and-granulocyte-macrophage-colony-stimulating-factor-gm-csf-in-aids-associated-large-cell-immuno-128749https://curecurrent.com/trials/anti-hiv-drugs-for-treating-infants-who-acquired-hiv-infection-at-birth-128750https://curecurrent.com/trials/trizivir-vs-kaletra-and-combivir-for-the-prevention-of-mother-to-child-transmission-of-hiv-128751https://curecurrent.com/trials/primary-prophylaxis-of-cerebral-toxoplasmosis-in-hiv-infected-patients-128752https://curecurrent.com/trials/drug-levels-of-tablet-and-liquid-forms-of-lamivudine-nevirapine-and-stavudine-in-hiv-infected-thai-children-128753https://curecurrent.com/trials/a-phase-i-multicenter-randomized-double-blind-trial-to-evaluate-the-safety-and-immunogenicity-of-recombinant-vaccinia-vi-128754https://curecurrent.com/trials/prophylaxis-against-tuberculosis-tb-in-patients-with-human-immunodeficiency-virus-hiv-infection-and-confirmed-latent-tub-128755https://curecurrent.com/trials/pilot-study-to-determine-the-feasibility-of-fluconazole-for-induction-treatment-and-suppression-of-relapse-of-histoplasm-128756https://curecurrent.com/trials/a-phase-i-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-100-mcg-of-env-2-3-in-mf59-128757https://curecurrent.com/trials/aerosols-in-the-treatment-of-asymptomatic-pneumocystis-pneumonia-a-pilot-study-assessing-the-effectiveness-of-aerosolize-128758https://curecurrent.com/trials/a-phase-i-multicenter-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-immuno-ag-recombinant-hiv-gp160-in-asy-128759https://curecurrent.com/trials/single-dose-pharmacokinetics-of-oral-dextran-sulfate-ua001-and-intravenous-dextran-sulfate-in-healthy-volunteers-128760https://curecurrent.com/trials/suppression-of-cytomegalovirus-retinitis-utilizing-high-dose-intravenous-acyclovir-and-oral-zidovudine-in-patients-with-128761https://curecurrent.com/trials/high-yield-hiv-testing-facilitated-linkage-to-care-and-prevention-for-female-youth-in-kenya-128762https://curecurrent.com/trials/evaluating-the-safety-and-tolerability-of-etravirine-in-hiv-1-infected-infants-and-children-128763https://curecurrent.com/trials/a-randomized-double-blind-protocol-comparing-amphotericin-b-with-flucytosine-to-amphotericin-b-alone-followed-by-a-compa-128764https://curecurrent.com/trials/randomized-comparative-study-of-fluconazole-versus-clotrimazole-troches-in-the-prevention-of-serious-fungal-infection-in-128765https://curecurrent.com/trials/safety-and-therapeutic-efficacy-of-the-vrc01-antibody-in-patients-who-initiated-antiretroviral-therapy-during-early-acut-128766https://curecurrent.com/trials/a-study-of-zidovudine-in-hiv-infected-patients-with-kidney-problems-128767https://curecurrent.com/trials/safety-and-pharmacokinetics-pk-of-raltegravir-in-hiv-human-immunodeficiency-virus-infected-children-and-adolescents-128768https://curecurrent.com/trials/a-phase-i-randomized-trial-to-evaluate-the-safety-and-immunogenicity-of-vaccinia-hiv-envelope-recombinant-vaccine-hivac-128769https://curecurrent.com/trials/preventive-treatment-against-tuberculosis-tb-in-patients-with-human-immunodeficiency-virus-hiv-infection-and-confirmed-l-128770https://curecurrent.com/trials/open-label-phase-i-study-to-evaluate-the-safety-of-combination-therapy-with-azt-and-interferon-beta-in-patients-with-aid-128771https://curecurrent.com/trials/a-phase-i-study-of-autologous-activated-cd8-lymphocytes-expanded-in-vitro-and-infused-with-or-without-recombinant-interl-128772https://curecurrent.com/trials/quadrivalent-hpv-vaccine-to-prevent-anal-hpv-in-hiv-infected-men-and-women-128773https://curecurrent.com/trials/a-phase-i-trial-of-recombinant-human-granulocyte-macrophage-colony-stimulating-factor-rhugm-csf-recombinant-alpha-interf-128774https://curecurrent.com/trials/treatment-of-acyclovir-resistant-mucocutaneous-herpes-simplex-disease-in-patients-with-aids-open-label-pilot-study-of-to-128775https://curecurrent.com/trials/pentoxifylline-trental-as-a-modulator-of-tumor-necrosis-factor-and-of-hiv-replication-in-patients-with-aids-128776https://curecurrent.com/trials/a-randomized-comparative-trial-of-zidovudine-azt-versus-2-3-dideoxyinosine-ddi-versus-azt-plus-ddi-in-symptomatic-hiv-in-128777https://curecurrent.com/trials/safety-and-effectiveness-of-lopinavir-ritonavir-in-hiv-infected-infants-128778https://curecurrent.com/trials/safety-immunogenicity-of-immunizations-of-alvac-dc-sc-vs-alvac-sc-128779https://curecurrent.com/trials/a-study-of-ribavirin-in-the-treatment-of-patients-with-aids-and-aids-related-problems-128780https://curecurrent.com/trials/safety-of-and-immune-response-to-an-adenoviral-hiv-1-vaccine-in-healthy-adults-128781https://curecurrent.com/trials/long-term-follow-up-of-hiv-infected-patients-who-have-previously-participated-in-hiv-clinical-trials-128782https://curecurrent.com/trials/a-study-of-dapd-alone-versus-dapd-plus-mmf-for-treatment-of-hiv-infection-128783https://curecurrent.com/trials/safety-of-and-immune-response-to-an-adenoviral-hiv-vaccine-vrc-hivadv014-00-vp-with-or-without-a-plasmid-hiv-vaccine-vrc-128784https://curecurrent.com/trials/comparison-of-two-methods-in-the-treatment-of-cytomegalovirus-of-the-eyes-in-patients-with-aids-128785https://curecurrent.com/trials/safety-and-acceptability-of-a-vaginal-microbicide-128786https://curecurrent.com/trials/safety-and-tolerance-of-indinavir-plus-ritonavir-in-hiv-positive-patients-failing-therapy-with-amprenavir-nelfinavir-or-128787https://curecurrent.com/trials/a-study-of-zidovudine-in-hiv-infected-pregnant-women-and-their-children-128788https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-treating-advanced-aids-patients-between-ages-4-and-22-with-7-drugs-some-at-hi-128789https://curecurrent.com/trials/safety-of-the-candidate-vaccine-c4-v3-alone-or-with-interleukin-12-il-12-in-hiv-infected-patients-receiving-effective-an-128790https://curecurrent.com/trials/safety-and-effectiveness-of-adding-either-an-hiv-vaccine-interleukin-2-or-both-to-a-patient-s-anti-hiv-drug-combination-128791https://curecurrent.com/trials/a-study-of-pentamidine-plus-dapsone-in-the-prevention-of-pneumocystis-carinii-pneumonia-pcp-in-hiv-infected-patients-who-128792https://curecurrent.com/trials/safety-tolerability-drug-interactions-and-antiviral-activity-of-rilpivirine-in-antiretroviral-naive-hiv-infected-childre-128793https://curecurrent.com/trials/a-two-year-study-of-the-clinical-efficacy-of-the-combination-of-emtricitabine-tenofovir-and-nevirapine-128794https://curecurrent.com/trials/effect-of-an-intrauterine-contraceptive-device-iud-in-hiv-infected-women-128795https://curecurrent.com/trials/safety-and-effectiveness-of-an-anti-hiv-drug-combination-with-and-without-hydroxyurea-in-patients-with-early-hiv-infecti-128796https://curecurrent.com/trials/a-comparison-of-the-effectiveness-safety-and-tolerability-of-two-different-hepatitis-c-treatments-in-patients-infected-w-128797https://curecurrent.com/trials/evaluating-the-safety-of-and-immune-response-to-an-hiv-vaccine-in-healthy-hiv-uninfected-adults-in-uganda-128798https://curecurrent.com/trials/a-study-of-amphotericin-b-in-the-treatment-of-fungal-infections-of-the-mouth-in-hiv-infected-patients-who-have-not-had-s-128799https://curecurrent.com/trials/combination-treatment-with-and-without-protease-inhibitors-for-women-who-begin-therapy-for-hiv-infection-during-pregnanc-128800https://curecurrent.com/trials/the-effect-of-fish-oil-plus-fenofibrate-on-triglyceride-levels-in-people-taking-highly-active-antiretroviral-therapy-haa-128801https://curecurrent.com/trials/safety-and-blood-levels-of-tenofovir-disoproxil-fumarate-in-hiv-infected-pregnant-women-and-their-babies-128802https://curecurrent.com/trials/a-study-of-itraconazole-in-preventing-the-return-of-histoplasmosis-a-fungal-infection-in-patients-with-aids-128803https://curecurrent.com/trials/safety-and-effectiveness-of-the-vaccine-alvac-hiv-vcp205-in-hiv-negative-adult-volunteers-in-uganda-128804https://curecurrent.com/trials/safety-of-and-immune-response-to-a-dna-hiv-vaccine-vrc-hivdna009-00-vp-in-hiv-infected-individuals-with-acute-hiv-infect-128805https://curecurrent.com/trials/comparing-the-safety-effectiveness-and-tolerability-of-three-anti-hiv-drug-regimens-for-treatment-naive-patients-128806https://curecurrent.com/trials/safety-of-recombinant-hiv-vaccines-in-hiv-infected-young-adults-on-stable-therapy-128807https://curecurrent.com/trials/nitazoxanide-for-the-treatment-of-chronic-diarrhea-in-hiv-infected-children-128808https://curecurrent.com/trials/safety-of-interleukin-7-in-hiv-infected-people-currently-taking-anti-hiv-drugs-128809https://curecurrent.com/trials/safety-tolerability-and-anti-hiv-activity-of-peg-intron-in-hiv-positive-children-128810https://curecurrent.com/trials/positive-affect-promotion-to-empower-optimal-adherence-to-hiv-therapy-128811https://curecurrent.com/trials/comparison-of-anti-hiv-drugs-used-alone-or-in-combination-with-cytosine-arabinoside-to-treat-progressive-multifocal-leuk-128812https://curecurrent.com/trials/a-study-of-nevirapine-to-prevent-hiv-transmission-from-mothers-to-their-infants-128813https://curecurrent.com/trials/safety-of-and-immune-response-to-an-investigational-hiv-1-vaccine-with-or-without-interleukin-12-il-12-in-hiv-1-infected-128814https://curecurrent.com/trials/effects-of-two-anti-hiv-drug-combinations-on-the-immune-systems-of-hiv-infected-patients-who-have-never-received-anti-hi-128815https://curecurrent.com/trials/safety-and-effectiveness-of-the-oral-hiv-entry-inhibitor-vicriviroc-in-hiv-infected-patients-128816https://curecurrent.com/trials/use-of-a-varicella-zoster-virus-vzv-vaccine-to-prevent-shingles-in-hiv-infected-children-who-have-already-had-chickenpox-128817https://curecurrent.com/trials/immune-system-function-following-vaccination-in-hiv-infected-children-taking-anti-hiv-drugs-128818https://curecurrent.com/trials/interleukin-2-il-2-pegylated-interferon-peg-ifn-alfa-2b-and-ribavirin-rbv-treatment-in-patients-with-hepatitis-c-and-hiv-128819https://curecurrent.com/trials/a-study-to-compare-anti-hiv-drugs-given-twice-a-day-or-once-a-day-with-or-without-direct-observation-128820https://curecurrent.com/trials/safety-and-effectiveness-of-the-selegiline-patch-for-decreased-mental-function-in-hiv-patients-128821https://curecurrent.com/trials/the-effectiveness-of-two-anti-hiv-treatments-in-hiv-infected-patients-128822https://curecurrent.com/trials/safety-of-amd070-when-administered-alone-or-boosted-with-low-dose-ritonavir-in-hiv-uninfected-men-128823https://curecurrent.com/trials/anti-hiv-activity-and-safety-of-3-different-doses-of-mifepristone-in-hiv-infected-people-128824https://curecurrent.com/trials/mycophenolate-mofetil-and-abacavir-treatment-in-hiv-patients-with-failed-anti-hiv-treatment-128825https://curecurrent.com/trials/safety-of-and-immune-response-to-two-influenza-vaccines-in-hiv-infected-children-and-adolescents-128826https://curecurrent.com/trials/treatment-of-hepatitis-b-virus-hbv-before-beginning-anti-hiv-drugs-in-patients-with-both-hbv-and-hiv-128827https://curecurrent.com/trials/interleukin-2-plus-anti-hiv-therapy-in-hiv-infected-children-with-weakened-immune-systems-128828https://curecurrent.com/trials/comparison-of-anti-hiv-drug-combinations-to-prevent-mother-to-child-transmission-of-hiv-128829https://curecurrent.com/trials/study-of-viral-load-decay-rates-in-hiv-infected-participants-starting-treatment-with-raltegravir-ral-and-emtricitabine-t-128830https://curecurrent.com/trials/immune-responses-in-hiv-positive-patients-receiving-an-anti-hiv-drug-combination-when-given-the-hiv-vaccines-remune-and-128831https://curecurrent.com/trials/evaluating-the-safety-and-efficacy-of-romidepsin-in-combination-with-antiretroviral-therapy-in-hiv-infected-adults-with-128832https://curecurrent.com/trials/a-study-of-as-101-in-patients-with-aids-or-aids-related-complex-arc-128833https://curecurrent.com/trials/a-study-to-evaluate-the-ability-of-tnfr-fc-to-decrease-the-amount-of-il-6-interleukin-6-and-tnf-alpha-tumor-necrosis-fac-128834https://curecurrent.com/trials/drug-interactions-of-amprenavir-and-efavirenz-in-combination-with-a-second-protease-inhibitor-in-hiv-negative-volunteers-128835https://curecurrent.com/trials/alveolar-macrophage-proteomics-in-hiv-associated-emphysema-128836https://curecurrent.com/trials/acetyl-l-carnitine-for-the-treatment-of-nrti-associated-peripheral-neuropathy-128837https://curecurrent.com/trials/safety-and-acceptability-of-the-anti-microbe-vaginal-gel-pmpa-gel-128838https://curecurrent.com/trials/safety-of-and-immune-response-to-an-hiv-1-vaccine-alvac-hiv-vcp1521-in-infants-born-to-hiv-infected-mothers-128839https://curecurrent.com/trials/antibiotics-to-reduce-chorioamnionitis-related-perinatal-hiv-transmission-128840https://curecurrent.com/trials/effects-of-anti-hiv-therapy-on-treatment-for-hepatitis-c-in-hcv-hiv-infected-adults-128841https://curecurrent.com/trials/three-month-course-of-anti-hiv-medications-for-people-recently-infected-with-hiv-128842https://curecurrent.com/trials/immune-response-to-a-therapeutic-hiv-vaccine-followed-by-treatment-interruption-in-patients-with-acute-or-recent-hiv-inf-128843https://curecurrent.com/trials/safety-of-saquinavir-and-high-doses-of-lopinavir-ritonavir-in-children-with-hiv-128844https://curecurrent.com/trials/evaluation-of-patients-who-have-not-had-success-with-zidovudine-128845https://curecurrent.com/trials/safety-of-tenofovir-disoproxil-fumarate-tdf-and-emtricitabine-tdf-in-hiv-infected-pregnant-women-and-their-infants-128846https://curecurrent.com/trials/evaluating-the-safety-of-tenofovir-vaginal-gel-in-hiv-uninfected-pregnant-women-128847https://curecurrent.com/trials/safety-and-effectiveness-of-a-three-drug-combination-treatment-for-recently-infected-or-converted-hiv-patients-128848https://curecurrent.com/trials/a-comparison-of-two-anti-hiv-drug-regimens-for-youth-who-have-failed-prior-therapy-128849https://curecurrent.com/trials/effect-of-interleukin-2-on-hiv-treatment-interruption-128850https://curecurrent.com/trials/safety-tolerability-and-blood-levels-of-ritonavir-boosted-atazanavir-and-rifampin-when-taken-together-in-hiv-uninfected-128851https://curecurrent.com/trials/safety-and-tolerability-of-a-therapeutic-dna-dendritic-cell-vaccine-in-hiv-infected-children-adolescents-and-young-adult-128852https://curecurrent.com/trials/a-study-of-zidovudine-in-hiv-infected-patients-who-have-hemophilia-128853https://curecurrent.com/trials/a-study-to-see-if-taking-one-or-two-extra-drugs-can-lower-hiv-levels-in-patients-who-have-failed-their-anti-hiv-drug-tre-128854https://curecurrent.com/trials/the-safety-and-effectiveness-of-hydroxyurea-and-ddi-used-individually-or-together-in-hiv-infected-patients-128855https://curecurrent.com/trials/interleukin-2-il-2-treatment-for-hiv-infected-patients-who-have-interrupted-their-anti-hiv-drug-therapy-128856https://curecurrent.com/trials/effects-of-therapeutic-hiv-vaccination-on-control-of-hiv-after-discontinuation-of-anti-hiv-drugs-128857https://curecurrent.com/trials/pneumococcal-vaccine-and-routine-pediatric-immunizations-in-hiv-infected-children-receiving-anti-hiv-drugs-128858https://curecurrent.com/trials/treatment-of-hepatitis-in-patients-who-are-triple-infected-with-hiv-hepatitis-b-virus-hbv-and-hepatitis-c-virus-hcv-128859https://curecurrent.com/trials/determining-responses-to-two-different-vaccines-in-hiv-and-hcv-infected-individuals-128860https://curecurrent.com/trials/intensive-viral-dynamics-substudy-of-a5248-128861https://curecurrent.com/trials/effects-of-buffergel-and-pro-2000-5-gel-in-men-128862https://curecurrent.com/trials/umbrella-study-for-hiv-infected-adults-enrolled-in-niaid-funded-interleukin-2-studies-128863https://curecurrent.com/trials/relationship-between-hiv-and-malaria-in-ugandan-children-128864https://curecurrent.com/trials/active-immunization-of-hiv-infected-pregnant-women-a-phase-i-study-of-safety-and-immunogenicity-of-a-rgp120-hiv-1-vaccin-128865https://curecurrent.com/trials/adding-new-drugs-for-hiv-infected-patients-failing-current-therapy-128866https://curecurrent.com/trials/the-effectiveness-of-nelfinavir-and-efavirenz-used-alone-or-together-combined-with-other-anti-hiv-drugs-in-patients-who-128867https://curecurrent.com/trials/a-study-of-hiv-disease-development-in-aging-128868https://curecurrent.com/trials/safety-and-effectiveness-of-fenofibrate-and-pravastatin-in-hiv-positive-patients-with-abnormal-blood-lipids-128869https://curecurrent.com/trials/vaccine-alvac-hiv-vcp1452-use-and-intermittent-withdrawal-of-anti-hiv-drugs-in-patients-with-hiv-128870https://curecurrent.com/trials/a-study-of-didanosine-use-alone-or-in-combination-with-zidovudine-in-infants-exposed-to-or-infected-with-hiv-128871https://curecurrent.com/trials/study-of-a-new-anti-hiv-drug-t-20-in-hiv-infected-children-128872https://curecurrent.com/trials/active-immunization-of-hiv-1-infected-pregnant-women-with-cd4-lymphocyte-counts-400-mm3-a-phase-i-study-of-safety-and-im-128873https://curecurrent.com/trials/the-safety-and-effectiveness-of-clarithromycin-and-rifabutin-used-alone-or-in-combination-to-prevent-mycobacterium-avium-128874https://curecurrent.com/trials/effect-of-vaccination-on-turnover-of-lamivudine-3tc-sensitive-and-resistant-virus-populations-in-hiv-1-infected-individu-128875https://curecurrent.com/trials/safety-of-and-immune-response-to-an-hiv-dna-plasmid-vaccine-followed-by-hiv-adenoviral-vector-vaccine-in-healthy-african-128876https://curecurrent.com/trials/atazanavir-ritonavir-maintenance-therapy-128877https://curecurrent.com/trials/effectiveness-of-giving-an-hiv-vaccine-remune-to-hiv-positive-patients-receiving-an-anti-hiv-drug-combination-128878https://curecurrent.com/trials/dual-versus-triple-protease-inhibitor-combinations-including-ritonavir-in-hiv-infected-people-128879https://curecurrent.com/trials/growth-hormone-treatment-of-children-with-hiv-associated-growth-failure-128880https://curecurrent.com/trials/using-drug-levels-and-drug-resistance-testing-to-select-effective-anti-hiv-drug-combinations-in-patients-with-drug-resis-128881https://curecurrent.com/trials/drug-interactions-between-lopinavir-ritonavir-and-oral-or-patch-contraceptives-in-hiv-infected-women-128882https://curecurrent.com/trials/a-study-of-megestrol-acetate-alone-or-in-combination-with-testosterone-enanthate-drug-in-the-treatment-of-hiv-associated-128883https://curecurrent.com/trials/a-comparison-of-adefovir-and-tenofovir-for-the-treatment-of-lamivudine-resistant-hepatitis-b-virus-in-people-with-hiv-128884https://curecurrent.com/trials/a-study-of-al721-in-hiv-infected-patients-with-swollen-lymph-nodes-128885https://curecurrent.com/trials/ritonavir-and-indinavir-in-children-failing-other-anti-hiv-treatment-128886https://curecurrent.com/trials/the-effectiveness-of-three-anti-hiv-drug-combinations-in-hiv-infected-patients-who-have-never-used-anti-hiv-drugs-128887https://curecurrent.com/trials/vaccinia-immune-globulin-in-treating-or-preventing-vaccinal-infection-128888https://curecurrent.com/trials/effects-of-immunization-with-hiv-1-immunogen-plus-anti-hiv-treatment-interruption-on-the-levels-of-hiv-128889https://curecurrent.com/trials/evaluating-the-safety-of-and-immune-response-to-an-hiv-vaccine-followed-by-booster-administered-by-two-devices-in-hiv-un-128890https://curecurrent.com/trials/a-multicenter-randomized-placebo-controlled-double-blinded-phase-i-trial-to-evaluate-the-safety-and-immunogenicity-of-li-128891https://curecurrent.com/trials/a-study-of-two-forms-of-pentamidine-in-hiv-infected-children-who-may-have-pneumocystis-carinii-pneumonia-128892https://curecurrent.com/trials/a-study-of-the-effectiveness-of-an-hiv-vaccine-alvac-vcp205-to-boost-immune-functions-in-hiv-negative-volunteers-who-hav-128893https://curecurrent.com/trials/safety-tolerability-and-effect-of-tmc207-and-efavirenz-in-healthy-volunteers-128894https://curecurrent.com/trials/a-study-of-abacavir-plus-indinavir-sulfate-plus-efavirenz-in-hiv-infected-patients-128895https://curecurrent.com/trials/the-safety-of-nevirapine-when-given-to-breast-feeding-babies-from-birth-to-age-6-months-128896https://curecurrent.com/trials/the-safety-and-effectiveness-of-interferon-alfa-2b-plus-didanosine-in-patients-with-kaposi-s-sarcoma-128897https://curecurrent.com/trials/effectiveness-of-early-or-delayed-addition-of-hydroxyurea-to-a-three-drug-anti-hiv-drug-combination-including-didanosine-128898https://curecurrent.com/trials/extended-follow-up-of-participants-in-preventive-hiv-vaccine-studies-in-uganda-128899https://curecurrent.com/trials/efavirenz-efv-in-hiv-infected-and-hiv-tuberculosis-tb-coinfected-children-128900https://curecurrent.com/trials/safety-and-effectiveness-of-low-dose-methotrexate-for-reducing-inflammation-in-hiv-infected-adults-on-arv-medications-128901https://curecurrent.com/trials/effect-of-an-enfuvirtide-based-anti-hiv-drug-regimen-on-latent-hiv-reservoirs-in-treatment-naive-adults-128902https://curecurrent.com/trials/administration-of-growth-hormone-to-increase-cd4-count-in-patients-taking-anti-hiv-drugs-128903https://curecurrent.com/trials/a-study-of-dextran-sulfate-in-hiv-infected-patients-and-in-patients-with-aids-or-aids-related-complex-arc-128904https://curecurrent.com/trials/safety-and-immune-response-to-a-recombinant-adenovirus-hiv-1-vaccine-in-healthy-adults-128905https://curecurrent.com/trials/a-comparison-of-three-drug-combinations-containing-clarithromycin-in-the-treatment-of-mycobacterium-avium-complex-mac-di-128906https://curecurrent.com/trials/safety-and-effectiveness-of-an-hiv-dna-vaccine-followed-by-an-hiv-adenoviral-vector-vaccine-for-prevention-of-hiv-infect-128907https://curecurrent.com/trials/interventional-study-of-mucosal-and-antimicrobial-responses-to-repeated-vaginal-applications-of-tenofovir-gel-in-hiv-uni-128908https://curecurrent.com/trials/a-study-of-pentamidine-in-the-prevention-of-pneumocystis-carinii-pneumonia-pcp-in-hiv-infected-children-who-cannot-take-128909https://curecurrent.com/trials/the-effects-of-anti-hiv-drugs-in-hiv-infected-patients-who-do-not-have-aids-128910https://curecurrent.com/trials/evaluating-the-safety-of-and-immune-response-to-an-hiv-vaccine-in-healthy-hiv-uninfected-adults-in-uganda-128911https://curecurrent.com/trials/preventing-cytomegalovirus-cmv-organ-damage-with-valganciclovir-in-people-with-hiv-128912https://curecurrent.com/trials/a-study-of-nitazoxanide-in-patients-with-aids-and-diarrhea-caused-by-cryptosporidium-128913https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-to-two-pneumococcal-vaccines-in-hiv-infected-pregnant-women-128914https://curecurrent.com/trials/blood-levels-of-abacavir-after-one-dose-in-hiv-infected-children-and-adolescents-128915https://curecurrent.com/trials/the-safety-and-effectiveness-of-zidovudine-in-the-treatment-of-hiv-infected-children-with-mild-to-moderate-symptoms-128916https://curecurrent.com/trials/a-study-to-compare-the-effectiveness-of-a-four-drug-anti-hiv-regimen-given-alone-or-in-combination-with-gm-csf-or-il-12-128917https://curecurrent.com/trials/a-study-on-the-effect-of-chemotherapy-combined-with-anti-hiv-drugs-in-hiv-positive-patients-128918https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerance-of-nelfinavir-nfv-given-with-zidovudine-zdv-and-lamivudine-3tc-in-hiv-posit-128919https://curecurrent.com/trials/a-study-to-test-the-safety-of-three-experimental-hiv-vaccines-128920https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerance-of-stavudine-d4t-in-combination-with-lamivudine-3tc-in-hiv-positive-pregnan-128921https://curecurrent.com/trials/a-multicenter-randomized-placebo-controlled-double-blind-trial-to-evaluate-the-safety-and-immunogenicity-of-an-hiv-1-pse-128922https://curecurrent.com/trials/a-phase-ii-iii-double-blind-study-of-amitriptyline-and-mexiletine-for-painful-neuropathy-in-hiv-infection-128923https://curecurrent.com/trials/a-study-on-the-management-of-combination-anti-hiv-drug-therapy-in-hiv-positive-children-with-prior-treatment-128924https://curecurrent.com/trials/a-randomized-trial-of-the-efficacy-and-safety-of-a-strategy-of-starting-with-nelfinavir-versus-ritonavir-added-to-backgr-128925https://curecurrent.com/trials/a-study-on-amprenavir-in-combination-with-other-anti-hiv-drugs-in-hiv-positive-patients-128926https://curecurrent.com/trials/a-study-of-chemotherapy-plus-ddi-or-ddc-in-the-treatment-of-aids-related-kaposi-s-sarcoma-128927https://curecurrent.com/trials/the-safety-of-zidovudine-plus-interferon-alpha-in-hiv-infected-children-128928https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-giving-il-2-alone-to-hiv-positive-patients-with-cd4-cell-counts-of-at-least-350-cells-128929https://curecurrent.com/trials/a-study-to-compare-two-anti-hiv-combination-therapies-each-containing-saquinavir-in-hiv-positive-children-128930https://curecurrent.com/trials/a-study-to-test-if-giving-remune-an-hiv-vaccine-can-improve-the-immune-systems-of-hiv-positive-patients-who-are-also-par-128931https://curecurrent.com/trials/safety-and-effectiveness-of-ritonavir-plus-lamivudine-plus-zidovudine-in-hiv-infected-pregnant-women-and-their-babies-128932https://curecurrent.com/trials/a-study-of-nevirapine-to-prevent-hiv-transmission-from-mothers-to-their-babies-128933https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-hydroxyurea-in-patients-on-potent-antiretroviral-therapy-and-who-have-less-th-128934https://curecurrent.com/trials/a-phase-i-trial-to-evaluate-didanosine-ddi-in-hiv-infected-pregnant-women-128935https://curecurrent.com/trials/the-effect-of-stomach-acid-on-foscarnet-128936https://curecurrent.com/trials/effects-of-mac-preventive-therapy-on-disease-causing-bacteria-in-hiv-infected-patients-a-substudy-of-cpcra-048-128937https://curecurrent.com/trials/five-drug-anti-hiv-treatment-followed-by-treatment-interruption-in-patients-who-have-recently-been-infected-with-hiv-128938https://curecurrent.com/trials/a-phase-ii-randomized-double-blind-placebo-controlled-trial-to-determine-the-efficacy-of-prednisone-therapy-in-hiv-assoc-128939https://curecurrent.com/trials/a-study-of-cidofovir-in-hiv-infected-children-with-cytomegalovirus-cmv-disease-128940https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-giving-proleukin-ril-2-to-hiv-positive-patients-with-cd4-counts-greater-than-300-cell-128941https://curecurrent.com/trials/a-study-of-ritonavir-an-anti-hiv-drug-in-hiv-positive-infants-and-children-128942https://curecurrent.com/trials/a-study-of-the-effects-of-advantage-24-on-the-rectum-128943https://curecurrent.com/trials/a-phase-i-study-of-methotrexate-for-hiv-infection-128944https://curecurrent.com/trials/the-effects-of-giving-interleukin-2-il-2-plus-anti-hiv-therapy-to-hiv-positive-patients-with-cd4-cell-counts-of-at-least-128945https://curecurrent.com/trials/a-study-to-compare-two-different-anti-hiv-drug-regimens-128946https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-nandrolone-decanoate-in-women-with-hiv-associated-weight-loss-128947https://curecurrent.com/trials/safety-and-effectiveness-of-azidothymidine-azt-in-hiv-positive-patients-with-hemophilia-128948https://curecurrent.com/trials/a-study-of-dideoxyinosine-ddi-in-hiv-infected-children-who-have-not-had-success-with-zidovudine-or-who-cannot-take-zidov-128949https://curecurrent.com/trials/a-randomized-phase-i-safety-and-immunogenicity-trial-of-live-recombinant-canarypox-alvac-hiv-vcp205-delivered-by-alterna-128950https://curecurrent.com/trials/a-study-to-compare-the-use-of-fluconazole-as-continuous-therapy-versus-periodic-therapy-in-hiv-positive-patients-with-re-128951https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-giving-interleukin-2-il-2-plus-anti-hiv-therapy-to-hiv-positive-patients-with-cd4-cel-128952https://curecurrent.com/trials/fortovase-saquinavir-given-with-low-dose-ritonavir-zidovudine-and-lamivudine-to-hiv-positive-pregnant-women-during-and-a-128953https://curecurrent.com/trials/an-open-trial-of-zidovudine-azt-treatment-of-the-aids-dementia-complex-in-patients-with-aids-or-low-cd4-lymphocyte-count-128954https://curecurrent.com/trials/a-study-to-test-the-safety-of-recombinant-interleukin-2-ril-2-in-hiv-infected-children-128955https://curecurrent.com/trials/a-phase-i-ii-double-blind-controlled-trial-to-determine-the-safety-and-immunogenicity-of-hiv-1-mn-rgp160-immuno-ag-vacci-128956https://curecurrent.com/trials/a-study-to-learn-more-about-mac-disease-and-the-use-of-anti-hiv-drugs-in-patients-with-advanced-hiv-infection-128957https://curecurrent.com/trials/active-hexose-correlated-compound-in-tuberculosis-hiv-human-immunodeficiency-virus-infection-128958https://curecurrent.com/trials/a-study-of-nonoxynol-9-n-9-and-hiv-infection-128959https://curecurrent.com/trials/a-study-of-the-effectiveness-of-different-anti-hiv-treatments-in-hiv-positive-individuals-who-have-been-on-a-protease-in-128960https://curecurrent.com/trials/a-study-to-compare-the-effectiveness-of-different-anti-hiv-drug-regimens-in-keeping-levels-of-hiv-in-the-blood-as-low-as-128961https://curecurrent.com/trials/a-phase-i-ii-pilot-treatment-study-of-csf-penetration-and-response-to-ganciclovir-and-foscarnet-in-cmv-neurologic-diseas-128962https://curecurrent.com/trials/an-open-prospective-multicenter-study-of-trimetrexate-with-leucovorin-rescue-for-aids-patients-with-pneumocystis-carinii-128963https://curecurrent.com/trials/safety-and-effectiveness-of-two-different-formulations-of-an-hiv-vaccine-in-infants-born-to-hiv-infected-women-128964https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-a-chickenpox-vaccine-in-hiv-infected-children-128965https://curecurrent.com/trials/study-of-how-indinavir-an-anti-hiv-drug-and-rifabutin-a-drug-used-to-treat-mac-an-hiv-associated-disease-interact-in-hiv-128966https://curecurrent.com/trials/the-effectiveness-of-gm-csf-in-hiv-positive-patients-who-are-also-receiving-anti-hiv-therapy-128967https://curecurrent.com/trials/effect-of-fluconazole-clarithromycin-and-rifabutin-on-the-pharmacokinetics-of-sulfamethoxazole-trimethoprim-and-dapsone-128968https://curecurrent.com/trials/safety-tolerability-and-anti-hiv-activity-of-dmp-266-efavirenz-in-combination-with-nelfinavir-in-hiv-positive-children-128969https://curecurrent.com/trials/the-effects-of-staggered-dosing-on-interactions-between-paired-combinations-of-nelfinavir-ritonavir-and-saquinavir-128970https://curecurrent.com/trials/effects-of-giving-interleukin-2-il-2-plus-anti-hiv-therapy-to-hiv-positive-patients-with-cd4-cell-counts-of-at-least-350-128971https://curecurrent.com/trials/the-safety-and-effectiveness-of-zidovudine-in-hiv-infected-pregnant-women-and-their-infants-128972https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerance-of-combination-anti-hiv-drug-therapy-indinavir-lamivudine-and-zidovudine-in-128973https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-interleukin-12-rhil-12-in-hiv-positive-patients-with-cd4-cell-counts-less-than-50-cel-128974https://curecurrent.com/trials/a-study-of-the-effects-of-giving-two-anti-hiv-vaccines-to-babies-of-hiv-positive-mothers-128975https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-hiv-1-gp120-c4-v3-hybrid-polyvalent-peptide-immunogen-mixed-in-mineral-oil-128976https://curecurrent.com/trials/a-study-to-evaluate-the-use-of-cidofovir-an-experimental-drug-for-the-treatment-of-progressive-multifocal-leukoencephalo-128977https://curecurrent.com/trials/a-study-on-possible-interactions-between-protease-inhibitors-anti-hiv-drugs-and-drugs-which-lower-the-level-of-fat-in-yo-128978https://curecurrent.com/trials/safety-and-effectiveness-of-tfv-1-gel-tdf-tablets-and-ftc-tdf-tablets-in-preventing-hiv-in-women-128979https://curecurrent.com/trials/a-phase-i-open-label-study-of-the-safety-tolerance-and-pharmacokinetic-interactions-of-combination-didanosine-and-ribavi-128980https://curecurrent.com/trials/a-study-of-wr-6026-in-the-treatment-of-pneumocystis-carinii-pneumonia-pcp-in-hiv-infected-patients-128981https://curecurrent.com/trials/the-safety-and-effects-of-1592u89-used-alone-or-in-combination-with-other-anti-hiv-drugs-in-hiv-infected-infants-and-chi-128982https://curecurrent.com/trials/phase-ii-evaluation-of-low-dose-oral-etoposide-for-the-treatment-of-relapsed-or-progressed-aids-related-kaposi-s-sarcoma-128983https://curecurrent.com/trials/an-escalating-dose-tolerance-trial-of-bg8962-rcd4-in-patients-who-are-hiv-antibody-positive-128984https://curecurrent.com/trials/pharmacokinetics-of-islatravir-in-participants-with-severe-renal-impairment-mk-8591-026-128985https://curecurrent.com/trials/dexamethasone-in-cryptococcal-meningitis-128986https://curecurrent.com/trials/a-study-to-test-the-safety-tolerance-and-metabolism-of-abacavir-1592u89-abc-with-standard-zidovudine-zdv-therapy-in-newb-128987https://curecurrent.com/trials/a-phase-i-dose-escalating-safety-and-tolerance-study-of-scd4-pe40-in-hiv-infected-persons-128988https://curecurrent.com/trials/a-phase-ii-double-blind-study-of-two-doses-of-sc-49483-in-combination-with-zidovudine-zdv-versus-zdv-128989https://curecurrent.com/trials/a-multicenter-randomized-placebo-controlled-double-blind-trial-to-evaluate-the-safety-and-immunogenicity-of-a-recombinan-128990https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-effectiveness-of-hiv-1-lai-gp120-an-hiv-vaccine-given-with-or-without-hiv-1-mn-rgp120-128991https://curecurrent.com/trials/a-comparative-study-of-combination-antiretroviral-therapy-in-children-and-adolescents-with-advanced-hiv-disease-128992https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-zidovudine-zdv-in-premature-infants-born-to-hiv-positive-women-128993https://curecurrent.com/trials/the-addition-of-indinavir-to-anti-hiv-treatment-in-hiv-infected-patients-128994https://curecurrent.com/trials/a-study-of-nevirapine-for-the-prevention-of-hiv-transmission-from-mothers-to-their-babies-128995https://curecurrent.com/trials/phase-i-safety-and-pharmacokinetics-study-of-microparticulate-atovaquone-m-atovaquone-566c80-in-hiv-infected-and-perinat-128996https://curecurrent.com/trials/a-phase-ii-study-of-low-dose-interleukin-2-by-subcutaneous-injection-in-combination-with-antiretroviral-therapy-versus-a-128997https://curecurrent.com/trials/a-multicenter-randomized-placebo-controlled-double-blind-trial-to-evaluate-the-safety-and-immunogenicity-of-the-therion-128998https://curecurrent.com/trials/active-immunization-of-hiv-1-infected-pregnant-women-with-cd4-lymphocyte-counts-400-mm3-a-phase-i-study-of-safety-and-im-128999https://curecurrent.com/trials/a-phase-i-study-of-combination-therapy-with-didanosine-ddi-and-ribavirin-in-hiv-infected-children-129000https://curecurrent.com/trials/a-phase-ii-comparative-study-of-seroconversion-of-single-dose-and-two-dose-measles-vaccination-in-hiv-infected-and-hiv-u-129001https://curecurrent.com/trials/a-phase-iii-study-to-evaluate-the-safety-tolerance-and-efficacy-of-early-treatment-with-zidovudine-azt-in-asymptomatic-i-129002https://curecurrent.com/trials/preventing-frequent-sinus-infections-in-hiv-infected-patients-129003https://curecurrent.com/trials/a-study-of-zidovudine-during-labor-and-delivery-in-hiv-infected-pregnant-women-129004https://curecurrent.com/trials/evaluation-of-the-interaction-between-high-dose-sulfamethoxazole-trimethoprim-and-zidovudine-129005https://curecurrent.com/trials/a-phase-i-ii-study-of-recombinant-interleukin-4-in-aids-and-kaposi-s-sarcoma-129006https://curecurrent.com/trials/safety-and-effectiveness-of-giving-indinavir-plus-stavudine-plus-lamivudine-to-hiv-infected-children-129007https://curecurrent.com/trials/chemoprevention-of-anal-neoplasia-arising-secondary-to-anogenital-human-papillomavirus-infection-in-persons-with-hiv-inf-129008